data_2js0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2js0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.562 0.696 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.591 ' HE3' ' HB3' ' A' ' 58' ' ' GLU . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.532 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.62 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.447 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.635 ' HZ2' ' HB3' ' A' ' 28' ' ' LYS . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HD3' HG12 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG21 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CE1' HG13 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.62 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 5' ' ' MET . 46.0 mt-10 . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.414 ' H ' ' HA ' ' A' ' 32' ' ' MET . 20.4 t-20 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.489 HG21 ' HH ' ' A' ' 44' ' ' TYR . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.451 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.663 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.647 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HB3' HD13 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.439 ' CE1' HG13 ' A' ' 56' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.643 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.643 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.326 0.584 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.516 ' HE1' ' HE2' ' A' ' 34' ' ' LYS . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 34' ' ' LYS . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.644 ' HB2' HG22 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.405 ' OH ' HG22 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.421 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.589 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.598 HG12 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.5 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.811 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.603 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 HD23 HD22 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 34' ' ' LYS . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.647 ' HB2' HG21 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.693 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.239 0.542 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HG12 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.466 ' HB2' ' HE1' ' A' ' 32' ' ' MET . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.532 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.631 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.666 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.666 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 51' ' ' PHE . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.477 ' CB ' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD2' ' CB ' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' ' 34' ' ' LYS . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.475 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.465 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG21 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.551 0.691 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.487 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 58' ' ' GLU . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HB3' HD23 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.628 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 29.7 mt-10 . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.55 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HB3' HG11 ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.415 ' HB2' ' HE1' ' A' ' 32' ' ' MET . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HE2' ' HA3' ' A' ' 42' ' ' GLY . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.47 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.337 0.589 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.652 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.453 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.652 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.533 ' HB3' HD23 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' GLY . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.585 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.44 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.446 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.516 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD21 HG12 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG12 HD21 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.436 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.51 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 18.9 mp0 . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.571 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.402 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.425 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.407 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.608 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 121.154 0.502 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.542 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.715 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' N ' HD22 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG13 ' HD3' ' A' ' 34' ' ' LYS . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 38' ' ' GLY . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 37' ' ' ASP . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.715 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.132 0.491 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.604 ' HA ' ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.679 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.663 HG21 ' HH ' ' A' ' 44' ' ' TYR . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.679 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.668 HG12 HD21 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.444 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.65 ' HG ' ' HB ' ' A' ' 30' ' ' ILE . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.663 ' HH ' HG21 ' A' ' 27' ' ' THR . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 7' ' ' ALA . 36.0 mt-10 . . . . . 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.579 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.706 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.521 ' CE1' HG12 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 44.8 mt-10 . . . . . 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.291 0.567 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB1' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.676 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.404 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.463 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.651 HG21 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 38.6 mt-10 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.664 HG23 ' HH ' ' A' ' 44' ' ' TYR . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HH ' HG23 ' A' ' 27' ' ' THR . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.479 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG12 HD23 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.482 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.776 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.415 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.566 ' HG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD12 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.664 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.664 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.552 ' CE1' HG13 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.458 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.43 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.623 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.722 HG21 ' HH ' ' A' ' 44' ' ' TYR . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 HD21 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.654 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.722 ' HH ' HG21 ' A' ' 27' ' ' THR . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.2 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 t -137.03 98.42 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 110.026 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -149.85 110.6 4.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.961 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 54.96 50.66 15.05 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.832 0.707 . . . . 0.0 110.53 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.591 ' HE3' ' HB3' ' A' ' 58' ' ' GLU . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.62 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.447 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.635 ' HZ2' ' HB3' ' A' ' 28' ' ' LYS . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG12 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.513 ' HD3' HG12 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG21 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.503 ' HB2' HD13 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.532 ' CE1' HG13 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.532 HG13 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.62 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HB3' ' HE3' ' A' ' 5' ' ' MET . 46.0 mt-10 -56.34 -67.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.56 91.37 0.17 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -120.56 5.83 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.468 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.019 178.858 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -76.98 83.85 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.864 0.364 . . . . 0.0 110.594 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.78 118.1 0.82 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.835 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.414 ' H ' ' HA ' ' A' ' 32' ' ' MET . 20.4 t-20 56.95 58.09 4.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.489 HG21 ' HH ' ' A' ' 44' ' ' TYR . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.451 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.663 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.647 ' HB2' HG22 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HB3' HD13 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG22 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.439 ' CE1' HG13 ' A' ' 56' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.643 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.643 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG13 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 61' ' ' ASP . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.7 -65.38 0.69 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -153.4 98.99 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.34 92.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.376 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 57' ' ' THR . 30.4 t70 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.988 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.854 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -81.4 127.19 32.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.083 0.468 . . . . 0.0 111.542 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.08 -33.17 21.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.09 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.43 74.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.516 ' HE1' ' HE2' ' A' ' 34' ' ' LYS . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.589 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD13 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 34' ' ' LYS . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.644 ' HB2' HG22 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.405 ' OH ' HG22 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.598 ' CE1' HG12 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.421 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.589 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.598 HG12 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.5 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 -84.03 -71.87 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -107.9 76.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.226 -174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.01 167.82 39.44 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.945 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.2 t -93.57 166.28 12.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 2' ' ' SER . 10.6 mp 69.14 23.0 6.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.997 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.93 42.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.189 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.811 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.603 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.603 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 HD23 HD22 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.421 HG11 ' HE2' ' A' ' 34' ' ' LYS . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.46 ' HA ' ' C ' ' A' ' 3' ' ' LEU . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.647 ' HB2' HG21 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.693 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.693 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.13 -78.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.56 88.63 2.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.726 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.36 -32.48 3.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.298 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.092 -177.531 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.991 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -96.68 -7.61 33.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 54.27 61.49 3.01 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -177.33 33.33 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.762 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB3' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.409 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HG12 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.466 ' HB2' ' HE1' ' A' ' 32' ' ' MET . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.532 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.631 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.544 ' HB3' HD12 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.666 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.666 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 51' ' ' PHE . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.14 -69.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.45 102.35 0.34 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.33 55.13 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.364 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.882 178.266 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -145.2 81.74 1.64 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.114 0.483 . . . . 0.0 109.729 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.23 -49.19 62.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.9 54.11 11.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.613 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.477 ' CB ' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' HD2' ' CB ' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' ' 34' ' ' LYS . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.475 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.465 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.583 ' HB2' HG21 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.583 HG21 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.546 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 -65.29 -73.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.54 35.55 3.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.673 0.749 . . . . 0.0 109.841 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.43 125.85 2.74 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.534 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.381 177.247 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -139.05 23.97 2.57 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.535 -0.391 . . . . 0.0 111.407 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.8 tp -90.35 -55.88 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 58.58 68.54 0.81 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.018 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.462 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD23 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.487 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' A' ' 58' ' ' GLU . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' HG22 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.504 ' HB3' HD23 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.509 HG22 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.539 ' HB2' HD13 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.628 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.452 HG13 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 29.7 mt-10 -76.52 -74.86 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.11 95.08 1.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.74 133.67 7.82 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.713 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -163.14 145.72 10.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.15 -63.19 1.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.107 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 57.1 31.1 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.55 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HB3' HG11 ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.415 ' HB2' ' HE1' ' A' ' 32' ' ' MET . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.409 ' HE2' ' HA3' ' A' ' 42' ' ' GLY . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.47 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.07 -70.33 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -160.85 26.71 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.922 0.867 . . . . 0.0 108.981 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.71 -40.04 0.3 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.443 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.139 -0.934 . . . . 0.0 108.865 173.521 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -131.25 174.23 10.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.22 -45.15 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.5 69.21 0.73 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HB2' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.516 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.652 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.453 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.652 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.533 ' HB3' HD23 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.61 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.45 -87.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -146.47 96.97 2.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.5 107.53 0.21 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.84 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 170.532 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -126.51 -2.7 6.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mp -109.72 66.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.929 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -175.62 31.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.16 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.446 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 42' ' ' GLY . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.585 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.44 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.585 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.446 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.15 -70.87 0.36 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -157.76 98.11 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.434 0.635 . . . . 0.0 110.064 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.43 -49.77 0.82 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.106 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.595 -177.582 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.703 -0.159 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.13 50.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.117 0.484 . . . . 0.0 112.085 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.6 mt -98.33 144.21 27.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 63.21 44.13 5.87 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' HB1' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.516 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD21 HG12 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG12 HD21 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.53 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.436 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.51 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.412 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.409 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.511 ' HG3' ' HB1' ' A' ' 7' ' ' ALA . 18.9 mp0 -83.38 -73.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -111.74 74.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.399 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.89 177.36 26.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.8 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.82 177.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -140.25 130.89 25.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.931 0.365 . . . . 0.0 110.44 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' A' ' 3' ' ' LEU . 4.2 mm? -74.41 176.65 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 62.5 44.47 7.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.571 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.857 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.425 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.407 ' HE2' ' HB2' ' A' ' 32' ' ' MET . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.608 ' HB2' HG21 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' CE1' HG11 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.599 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.453 HG11 ' CE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.2 -89.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -128.7 82.17 2.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.66 -167.42 11.22 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.849 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.531 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 p -149.09 160.05 43.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.727 -0.278 . . . . 0.0 110.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -85.84 -36.1 20.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.865 0.364 . . . . 0.0 110.57 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 56.83 58.17 4.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.641 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.715 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.525 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' N ' HD22 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.542 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG13 ' HD3' ' A' ' 34' ' ' LYS . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 38' ' ' GLY . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' H ' ' CG ' ' A' ' 37' ' ' ASP . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.623 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.715 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 -62.28 -75.4 0.07 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.4 84.68 2.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.83 151.3 44.5 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.92 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 32' ' ' MET . 16.3 m -70.97 164.27 25.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.973 0.415 . . . . 0.0 110.733 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.22 -41.17 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.878 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.33 85.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.537 0.523 . . . . 0.0 111.006 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.604 ' HA ' ' HE3' ' A' ' 5' ' ' MET . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.679 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD22 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.663 HG21 ' HH ' ' A' ' 44' ' ' TYR . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.679 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.668 HG12 HD21 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.65 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 2' ' ' SER . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.65 ' HG ' ' HB ' ' A' ' 30' ' ' ILE . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.663 ' HH ' HG21 ' A' ' 27' ' ' THR . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.459 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 36.0 mt-10 -92.17 -65.03 1.04 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 4.2 mm-40 -167.71 106.46 0.54 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.926 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.75 22.76 74.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.386 172.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.767 178.612 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.0 p 54.82 174.41 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.482 1.113 . . . . 0.0 112.324 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 32' ' ' MET . 3.5 mm? -84.93 171.73 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 178.58 69.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.854 0.722 . . . . 0.0 109.332 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.401 ' HE3' ' HG3' ' A' ' 59' ' ' GLU . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.579 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.533 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.706 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.521 ' CE1' HG12 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 34' ' ' LYS . 44.8 mt-10 -58.43 -80.46 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HG3' ' HE3' ' A' ' 5' ' ' MET . 41.1 mt-10 -134.02 84.69 2.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.539 . . . . 0.0 110.421 176.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.83 -140.47 4.04 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.801 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.397 -178.03 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -121.38 9.48 10.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.13 0.49 . . . . 0.0 110.325 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 4' ' ' ASN . 1.5 tt -100.66 133.91 44.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.256 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 67.09 51.22 0.95 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.742 0.652 . . . . 0.0 110.59 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB1' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.676 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.463 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.651 ' HB2' HG21 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.559 ' HB3' HD22 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.651 HG21 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.61 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.56 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 38.6 mt-10 -93.64 -67.36 0.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -148.7 93.39 2.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.132 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.41 24.96 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.625 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -83.87 81.57 8.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.03 -67.18 0.22 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.436 0.695 . . . . 0.0 111.341 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 56.4 48.1 17.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.664 HG23 ' HH ' ' A' ' 44' ' ' TYR . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.436 ' HE1' ' HB2' ' A' ' 32' ' ' MET . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HH ' HG23 ' A' ' 27' ' ' THR . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.479 HD21 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.02 -72.71 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -162.73 100.06 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.498 163.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.71 -107.98 0.2 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.092 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.934 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -86.45 97.2 10.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.018 0.437 . . . . 0.0 111.789 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 mt -137.62 18.25 2.89 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.098 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -179.58 40.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.772 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.423 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG12 HD23 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.482 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.776 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.776 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.415 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.566 ' HG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD12 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG22 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 -58.22 -73.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -149.98 19.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.348 1.07 . . . . 0.0 108.583 166.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.04 106.24 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.355 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.657 -170.524 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -64.77 107.66 1.51 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.421 . . . . 0.0 111.574 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.0 174.98 9.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.793 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 58.43 49.03 11.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.664 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.664 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.552 ' CE1' HG13 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.458 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 -66.24 -77.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -132.94 85.51 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.35 -125.19 2.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.156 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.151 -177.435 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 p -86.46 119.25 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mp -85.24 62.31 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.273 0.559 . . . . 0.0 109.828 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -167.65 56.79 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.766 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.43 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.623 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.722 HG21 ' HH ' ' A' ' 44' ' ' TYR . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 HD21 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 32' ' ' MET . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.654 ' HB2' HG21 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.722 ' HH ' HG21 ' A' ' 27' ' ' THR . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.2 mp0 -65.91 -69.46 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -173.86 27.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.846 0.831 . . . . 0.0 108.767 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.62 166.53 34.47 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.225 -170.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.619 -0.79 . . . . 0.0 108.91 177.329 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.562 0.696 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.63 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HG11 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.543 ' CE1' HG11 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG11 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.63 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 29' ' ' VAL . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG11 HD22 ' A' ' 23' ' ' LEU . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.639 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.597 ' HB3' HD11 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.326 0.584 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.424 HG21 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.66 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' OH ' HG21 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.592 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.821 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 HD23 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.5 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.239 0.542 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.589 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' HD11 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.673 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 44' ' ' TYR . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HD22 ' A' ' 23' ' ' LEU . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 21' ' ' LEU . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.552 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.522 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.551 0.691 . . . . 0.0 111.018 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.479 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.611 ' HA ' HG23 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.644 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 29.7 mt-10 . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.578 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' HB3' HG23 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 21' ' ' LEU . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.337 0.589 . . . . 0.0 110.585 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.534 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.665 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HG2' ' ND2' ' A' ' 4' ' ' ASN . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.665 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' HD21 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HG3' ' A' ' 17' ' ' ARG . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.68 HD22 HG11 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.68 HG11 HD22 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.523 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 18.9 mp0 . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.601 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.874 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 29' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 23' ' ' LEU . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.626 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG21 ' HE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 121.154 0.502 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.728 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' A' ' 17' ' ' ARG . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.59 ' HE1' HG21 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.728 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG21 ' HE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 53.1 m-80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.132 0.491 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.562 ' HE2' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' HE2' ' A' ' 5' ' ' MET . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.703 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 48' ' ' VAL . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' HD21 ' A' ' 21' ' ' LEU . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 36.0 mt-10 . . . . . 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.591 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.732 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.591 ' HB3' HG23 ' A' ' 48' ' ' VAL . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HB3' HD21 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HG11 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.552 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.291 0.567 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 29' ' ' VAL . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 23' ' ' LEU . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.473 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.63 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 38.6 mt-10 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 21' ' ' LEU . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.417 ' HE2' HG21 ' A' ' 56' ' ' VAL . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 51' ' ' PHE . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.791 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.791 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' HB3' HD11 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' TYR . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.476 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.642 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.446 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 17' ' ' ARG . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.665 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 7.2 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 t -137.03 98.42 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 110.026 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -149.85 110.6 4.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.961 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 54.96 50.66 15.05 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.832 0.707 . . . . 0.0 110.53 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.63 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HG11 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.543 ' CE1' HG11 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG11 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.63 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.34 -67.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.56 91.37 0.17 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -120.56 5.83 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.468 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.019 178.858 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -76.98 83.85 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.864 0.364 . . . . 0.0 110.594 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.78 118.1 0.82 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.835 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.47 ' H ' ' HA ' ' A' ' 32' ' ' MET . 20.4 t-20 56.95 58.09 4.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 29' ' ' VAL . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG11 HD22 ' A' ' 23' ' ' LEU . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.47 ' HA ' ' H ' ' A' ' 4' ' ' ASN . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.639 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.597 ' HB3' HD11 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 61' ' ' ASP . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.7 -65.38 0.69 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -153.4 98.99 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.34 92.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.376 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.771 ' HB2' HG21 ' A' ' 57' ' ' THR . 30.4 t70 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.988 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.854 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -81.4 127.19 32.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.083 0.468 . . . . 0.0 111.542 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.08 -33.17 21.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.09 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.43 74.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.424 HG21 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.66 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' OH ' HG21 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.592 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 -84.03 -71.87 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -107.9 76.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.226 -174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.01 167.82 39.44 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.945 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.2 t -93.57 166.28 12.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 2' ' ' SER . 10.6 mp 69.14 23.0 6.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.997 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.93 42.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.189 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.821 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 HD23 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.468 ' HA ' ' C ' ' A' ' 3' ' ' LEU . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.5 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.13 -78.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.56 88.63 2.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.726 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.36 -32.48 3.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.298 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.092 -177.531 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.991 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -96.68 -7.61 33.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 54.27 61.49 3.01 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -177.33 33.33 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.762 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.589 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' HD11 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.673 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.14 -69.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.45 102.35 0.34 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.33 55.13 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.364 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.882 178.266 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -145.2 81.74 1.64 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.114 0.483 . . . . 0.0 109.729 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.23 -49.19 62.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.9 54.11 11.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.613 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 44' ' ' TYR . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HD22 ' A' ' 23' ' ' LEU . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 21' ' ' LEU . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.552 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 -65.29 -73.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.54 35.55 3.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.673 0.749 . . . . 0.0 109.841 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.43 125.85 2.74 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.534 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.381 177.247 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -139.05 23.97 2.57 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.535 -0.391 . . . . 0.0 111.407 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.8 tp -90.35 -55.88 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 58.58 68.54 0.81 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.018 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.611 ' HA ' HG23 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.644 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 29.7 mt-10 -76.52 -74.86 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.11 95.08 1.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.74 133.67 7.82 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.713 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -163.14 145.72 10.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.15 -63.19 1.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.107 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 57.1 31.1 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.578 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' HB3' HG23 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 21' ' ' LEU . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.07 -70.33 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -160.85 26.71 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.922 0.867 . . . . 0.0 108.981 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.71 -40.04 0.3 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.443 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.139 -0.934 . . . . 0.0 108.865 173.521 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -131.25 174.23 10.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.22 -45.15 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.5 69.21 0.73 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.534 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.665 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.665 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' HD21 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.45 -87.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -146.47 96.97 2.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.5 107.53 0.21 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.84 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 170.532 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -126.51 -2.7 6.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 32' ' ' MET . 11.1 mp -109.72 66.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.929 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -175.62 31.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.16 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.15 -70.87 0.36 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -157.76 98.11 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.434 0.635 . . . . 0.0 110.064 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.43 -49.77 0.82 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.106 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.595 -177.582 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.703 -0.159 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.13 50.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.117 0.484 . . . . 0.0 112.085 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.6 mt -98.33 144.21 27.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 63.21 44.13 5.87 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HG3' ' A' ' 17' ' ' ARG . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.68 HD22 HG11 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.68 HG11 HD22 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.523 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 18.9 mp0 -83.38 -73.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -111.74 74.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.399 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.89 177.36 26.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.8 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.82 177.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -140.25 130.89 25.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.931 0.365 . . . . 0.0 110.44 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.2 mm? -74.41 176.65 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 62.5 44.47 7.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.601 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.874 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 29' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 23' ' ' LEU . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.626 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG21 ' HE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.2 -89.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -128.7 82.17 2.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.66 -167.42 11.22 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.849 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.531 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 p -149.09 160.05 43.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.727 -0.278 . . . . 0.0 110.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -85.84 -36.1 20.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.865 0.364 . . . . 0.0 110.57 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 56.83 58.17 4.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.641 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.728 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' A' ' 17' ' ' ARG . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.59 ' HE1' HG21 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.728 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG21 ' HE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 -62.28 -75.4 0.07 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.4 84.68 2.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.83 151.3 44.5 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.92 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 32' ' ' MET . 16.3 m -70.97 164.27 25.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.973 0.415 . . . . 0.0 110.733 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.22 -41.17 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.878 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 53.1 m-80 65.33 85.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.537 0.523 . . . . 0.0 111.006 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.562 ' HE2' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' HE2' ' A' ' 5' ' ' MET . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.703 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.497 ' O ' ' HB3' ' A' ' 2' ' ' SER . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 48' ' ' VAL . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' HD21 ' A' ' 21' ' ' LEU . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 36.0 mt-10 -92.17 -65.03 1.04 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 4.2 mm-40 -167.71 106.46 0.54 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.926 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.75 22.76 74.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.386 172.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.767 178.612 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.0 p 54.82 174.41 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.482 1.113 . . . . 0.0 112.324 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 32' ' ' MET . 3.5 mm? -84.93 171.73 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 178.58 69.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.854 0.722 . . . . 0.0 109.332 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.591 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.732 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.591 ' HB3' HG23 ' A' ' 48' ' ' VAL . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HB3' HD21 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HG11 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.552 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.43 -80.46 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -134.02 84.69 2.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.539 . . . . 0.0 110.421 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.83 -140.47 4.04 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.801 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.397 -178.03 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -121.38 9.48 10.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.13 0.49 . . . . 0.0 110.325 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 4' ' ' ASN . 1.5 tt -100.66 133.91 44.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.256 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 67.09 51.22 0.95 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.742 0.652 . . . . 0.0 110.59 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 29' ' ' VAL . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 23' ' ' LEU . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.473 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.63 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 38.6 mt-10 -93.64 -67.36 0.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -148.7 93.39 2.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.132 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.41 24.96 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.625 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -83.87 81.57 8.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.03 -67.18 0.22 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.436 0.695 . . . . 0.0 111.341 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 56.4 48.1 17.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 21' ' ' LEU . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.417 ' HE2' HG21 ' A' ' 56' ' ' VAL . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 51' ' ' PHE . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.02 -72.71 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -162.73 100.06 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.498 163.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.71 -107.98 0.2 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.092 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.934 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -86.45 97.2 10.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.018 0.437 . . . . 0.0 111.789 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 mt -137.62 18.25 2.89 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.098 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -179.58 40.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.772 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.791 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.791 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' HB3' HD11 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 -58.22 -73.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -149.98 19.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.348 1.07 . . . . 0.0 108.583 166.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.04 106.24 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.355 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.657 -170.524 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -64.77 107.66 1.51 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.421 . . . . 0.0 111.574 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.0 174.98 9.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.793 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 58.43 49.03 11.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' TYR . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 -66.24 -77.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -132.94 85.51 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.35 -125.19 2.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.156 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.151 -177.435 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 p -86.46 119.25 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mp -85.24 62.31 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.273 0.559 . . . . 0.0 109.828 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -167.65 56.79 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.766 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.476 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.642 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.446 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 17' ' ' ARG . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.665 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 7.2 mp0 -65.91 -69.46 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -173.86 27.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.846 0.831 . . . . 0.0 108.767 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.62 166.53 34.47 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.225 -170.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.619 -0.79 . . . . 0.0 108.91 177.329 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 121.562 0.696 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.63 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HG11 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.543 ' CE1' HG11 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG11 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.63 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 29' ' ' VAL . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.558 HG11 HD22 ' A' ' 23' ' ' LEU . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.639 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.597 ' HB3' HD11 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 . . . . . 0 N--CA 1.468 0.426 0 CA-C-O 121.326 0.584 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.424 HG21 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.66 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' OH ' HG21 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.592 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 54' ' ' ASN . 0.9 OUTLIER -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 . . . . . 0 N--CA 1.464 0.229 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.821 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 HD23 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.5 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.239 0.542 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.589 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' HD11 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.673 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.589 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 44' ' ' TYR . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HD22 ' A' ' 23' ' ' LEU . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 21' ' ' LEU . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.552 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.551 0.691 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.479 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.611 ' HA ' HG23 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.644 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 29.7 mt-10 . . . . . 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.578 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' HB3' HG23 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 21' ' ' LEU . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.337 0.589 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.534 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.665 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.665 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' HD21 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HG3' ' A' ' 17' ' ' ARG . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.68 HD22 HG11 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.68 HG11 HD22 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.523 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 18.9 mp0 . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.601 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.874 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 29' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 23' ' ' LEU . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.626 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG21 ' HE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 121.154 0.502 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.728 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' A' ' 17' ' ' ARG . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.59 ' HE1' HG21 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.728 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG21 ' HE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 53.1 m-80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 121.132 0.491 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.562 ' HE2' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' HE2' ' A' ' 5' ' ' MET . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' HE22 ' A' ' 47' ' ' GLN . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.703 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 48' ' ' VAL . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' HD21 ' A' ' 21' ' ' LEU . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 15' ' ' ALA . 51.5 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 54' ' ' ASN . 2.3 t-20 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 36.0 mt-10 . . . . . 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.591 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.732 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.591 ' HB3' HG23 ' A' ' 48' ' ' VAL . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HB3' HD21 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HG11 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.552 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.291 0.567 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 29' ' ' VAL . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 23' ' ' LEU . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.473 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.63 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.474 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 38.6 mt-10 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 21' ' ' LEU . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.417 ' HE2' HG21 ' A' ' 56' ' ' VAL . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 51' ' ' PHE . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.791 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.791 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' HB3' HD11 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 . . . . . 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.429 HD22 ' H ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' TYR . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 . . . . . 0 N--CA 1.463 0.179 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.476 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.642 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.446 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 17' ' ' ARG . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.593 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.665 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 7.2 mp0 . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.337 -0.305 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 t -137.03 98.42 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.946 0.403 . . . . 0.0 110.026 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -149.85 110.6 4.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.961 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 54.96 50.66 15.05 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.832 0.707 . . . . 0.0 110.53 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 25.8 ttt -90.33 119.18 69.21 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.917 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.559 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 11.4 Cg_exo -70.62 133.86 24.91 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.113 1.876 . . . . 0.0 111.459 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.38 128.35 31.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.093 0.473 . . . . 0.0 110.177 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 19.2 m-85 -91.03 129.49 37.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.2 t -68.61 128.82 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.256 0.55 . . . . 0.0 111.752 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.63 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 21.9 mmtp -74.43 -58.74 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.076 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.99 158.84 43.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -63.34 122.53 16.43 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.09 0.472 . . . . 0.0 111.026 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 83.7 t80 -127.57 114.81 17.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.069 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.16 124.51 29.32 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.343 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.43 126.28 31.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.48 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HB3' ' OE2' ' A' ' 20' ' ' GLU . 8.5 tp10 -86.83 -49.39 7.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.779 0.323 . . . . 0.0 111.41 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -107.05 -172.26 2.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.59 -35.87 68.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.093 -171.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -97.73 8.57 44.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 16' ' ' GLU . 35.7 mt-10 -90.43 147.84 23.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.039 173.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.3 tm? -112.82 118.0 33.71 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.218 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -72.0 135.48 46.41 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.244 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 60.1 mt -119.27 140.3 50.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.277 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.1 mm -122.94 122.16 65.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.778 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -53.64 120.69 6.52 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.15 -23.97 15.27 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.972 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.4 p -93.87 -176.91 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.763 0.281 . . . . 0.0 111.043 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 5.7 ttpm? -136.39 140.31 43.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.66 159.66 17.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mm -101.85 107.67 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.373 . . . . 0.0 110.333 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.548 HG11 ' HD3' ' A' ' 34' ' ' LYS . 40.1 t -84.14 127.35 39.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.995 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.0 mtm -115.39 -50.69 2.72 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.061 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 8.8 tp10 -107.88 131.47 54.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.427 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HG11 ' A' ' 31' ' ' VAL . 40.2 mtmt -135.5 117.61 15.42 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.1 m -84.17 -177.29 6.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 p -82.05 -1.91 50.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 111.173 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -123.63 -162.12 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.356 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.01 2.03 82.44 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.444 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.64 109.13 21.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.804 0.802 . . . . 0.0 111.848 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 45.0 m0 -106.65 161.07 14.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.806 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -125.28 117.6 24.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.542 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.08 171.2 27.06 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.291 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.4 t -112.81 132.3 55.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.19 0.519 . . . . 0.0 111.251 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.545 ' HB3' HD21 ' A' ' 21' ' ' LEU . 67.5 t80 -116.21 114.37 24.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -20.46 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.948 1.405 . . . . 0.0 113.751 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.54 -45.17 1.08 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.791 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -143.62 160.71 40.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 111.001 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.2 p -122.42 157.88 26.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.83 -157.1 28.55 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.197 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -91.99 139.43 30.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.041 0.448 . . . . 0.0 111.539 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.543 ' CE1' HG11 ' A' ' 56' ' ' VAL . 44.6 p90 -143.83 150.15 48.88 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.273 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.24 132.17 19.01 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.726 2.284 . . . . 0.0 112.315 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.7 p -61.64 -29.05 69.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.259 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 -9.82 58.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.544 0.212 . . . . 0.0 111.451 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -103.39 8.46 38.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG11 ' CE1' ' A' ' 51' ' ' PHE . 16.4 m -129.85 145.7 35.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.895 0.855 . . . . 0.0 113.158 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.63 ' OG1' ' HE3' ' A' ' 10' ' ' LYS . 89.0 m -101.93 105.31 16.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.467 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.34 -67.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.56 91.37 0.17 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -120.56 5.83 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.468 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.019 178.858 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.399 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -76.98 83.85 3.51 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.864 0.364 . . . . 0.0 110.594 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.78 118.1 0.82 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.835 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.47 ' H ' ' HA ' ' A' ' 32' ' ' MET . 20.4 t-20 56.95 58.09 4.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.597 0.713 . . . . 0.0 110.011 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.6 mtp -104.17 120.58 50.45 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.359 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.549 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.9 Cg_exo -68.16 131.27 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.392 2.061 . . . . 0.0 111.323 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.5 129.98 37.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.233 0.54 . . . . 0.0 110.643 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 5.1 m-85 -87.61 123.57 32.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.874 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.28 129.82 27.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.062 0.458 . . . . 0.0 111.532 -176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 51.8 mmtt -75.64 -55.07 6.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.07 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.17 160.61 39.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -61.2 122.81 15.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.963 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 92.7 t80 -127.55 100.56 6.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.442 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 45.1 tpp -80.07 122.67 27.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.301 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.83 145.58 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.31 -57.88 1.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -83.39 166.41 18.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.668 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.92 -24.99 59.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.126 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.4 2.91 51.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.095 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.86 166.96 12.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.038 171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 44' ' ' TYR . 30.2 tp -123.22 124.29 42.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.359 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.4 p -76.75 118.44 19.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.483 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 29' ' ' VAL . 42.9 mt -109.19 141.19 41.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.741 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.3 mm -123.34 119.84 58.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.071 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 22.6 ttpt -55.08 121.96 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.41 -17.24 21.47 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.245 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 82.6 p -105.72 178.39 4.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.9 ttpt -136.23 132.8 36.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.409 -173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.558 HG11 HD22 ' A' ' 23' ' ' LEU . 3.0 m -110.72 165.86 5.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 -178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mm -105.92 105.38 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.475 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 32.7 t -82.78 116.94 27.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.47 ' HA ' ' H ' ' A' ' 4' ' ' ASN . 30.7 mtm -99.46 -53.38 3.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.013 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.41 123.4 49.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.389 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 50.4 mtpt -108.11 120.76 43.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -82.37 146.62 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.75 -31.0 66.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.05 0.452 . . . . 0.0 111.452 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -154.51 151.1 28.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.548 173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.96 -123.92 7.9 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.892 177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -93.54 143.79 25.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.05 0.452 . . . . 0.0 111.676 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 28.6 m0 -111.58 144.95 40.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.596 173.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.78 110.14 21.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.152 0.501 . . . . 0.0 110.248 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.86 164.0 25.0 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.189 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.639 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.9 t -113.85 144.36 43.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.049 0.452 . . . . 0.0 110.558 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.597 ' HB3' HD11 ' A' ' 21' ' ' LEU . 86.0 t80 -146.57 137.21 23.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.746 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 68.11 -90.1 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.791 0.682 . . . . 0.0 110.2 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.37 6.17 1.93 Allowed Glycine 0 C--N 1.312 -0.776 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.525 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -116.22 173.44 6.59 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.8 p -138.35 165.54 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.13 -158.56 29.91 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.832 -1.175 . . . . 0.0 112.787 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -104.48 135.1 46.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.096 0.474 . . . . 0.0 111.259 -174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.467 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 37.8 p90 -133.49 150.58 75.39 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.32 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.652 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 17.4 Cg_exo -67.72 134.55 32.96 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.497 2.131 . . . . 0.0 111.585 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.2 p -66.42 -14.02 61.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.908 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -77.68 -8.46 57.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.427 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 87.5 m-85 -111.67 14.59 21.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG11 ' CE1' ' A' ' 51' ' ' PHE . 9.6 m -129.83 168.67 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.842 0.829 . . . . 0.0 113.088 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.771 HG21 ' HB2' ' A' ' 61' ' ' ASP . 65.0 m -134.68 111.47 10.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.428 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.7 -65.38 0.69 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.742 0.306 . . . . 0.0 110.834 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -153.4 98.99 2.31 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.91 0.386 . . . . 0.0 110.743 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 131.34 92.11 0.57 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.556 -0.831 . . . . 0.0 113.376 174.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.771 ' HB2' HG21 ' A' ' 57' ' ' THR . 30.4 t70 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.508 -0.758 . . . . 0.0 109.988 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.854 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 m -81.4 127.19 32.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.083 0.468 . . . . 0.0 111.542 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -86.08 -33.17 21.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.09 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.43 74.38 0.38 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.3 mtm -108.71 124.33 34.64 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.375 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 7.7 Cg_exo -72.83 132.35 18.39 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.531 2.154 . . . . 0.0 111.79 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -132.92 128.53 36.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.038 0.446 . . . . 0.0 110.771 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 28' ' ' LYS . 15.5 m-85 -81.86 137.96 35.15 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.126 -177.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.6 t -83.49 125.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.422 . . . . 0.0 110.402 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 46.8 mtmt -88.32 -37.37 16.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.858 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 99.5 m-85 -136.02 146.84 47.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -68.43 127.45 33.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.084 0.468 . . . . 0.0 110.331 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.4 t80 -129.57 101.35 5.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -81.96 108.26 15.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.014 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.03 151.79 40.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.9 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -124.95 -36.73 2.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.852 0.358 . . . . 0.0 110.884 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -85.81 165.32 16.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.366 0.603 . . . . 0.0 111.633 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -72.91 -26.65 61.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.078 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.0 p-10 -91.73 19.45 6.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.124 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -118.51 160.73 21.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.383 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 65.4 tp -125.15 129.94 51.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.834 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 p -75.3 116.56 16.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.752 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 51' ' ' PHE . 76.8 mt -106.25 144.64 32.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.611 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.02 117.68 53.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.247 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -54.94 120.97 7.67 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.85 1.53 32.1 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.774 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.424 HG21 ' OH ' ' A' ' 44' ' ' TYR . 60.6 p -119.16 -173.3 2.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 0.0 111.062 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 32.0 ttpt -145.16 132.8 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.054 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.4 167.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.738 0.304 . . . . 0.0 110.783 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mm -104.66 104.2 16.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.347 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 42.0 t -86.12 106.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.059 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 32' ' ' MET . 31.4 mtm -82.33 -53.54 5.95 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.329 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.41 141.25 39.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.333 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 46.9 mtmt -121.86 136.03 54.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.733 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 36' ' ' SER . 41.4 t -99.91 -178.17 3.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.916 -178.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.403 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 13.3 p -81.96 1.16 36.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.424 0.63 . . . . 0.0 110.403 177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -92.49 170.24 9.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.934 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.46 2.16 68.28 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.313 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -108.2 124.95 51.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.761 0.315 . . . . 0.0 110.703 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 42.0 m0 -111.26 152.3 27.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.675 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 41' ' ' ARG . 31.7 ttt85 -99.25 106.27 18.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.237 0.541 . . . . 0.0 110.359 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.2 161.6 26.0 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.317 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.66 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.6 t -117.59 146.07 43.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.582 0.23 . . . . 0.0 110.468 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' OH ' HG21 ' A' ' 27' ' ' THR . 46.9 t80 -147.57 123.41 10.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.406 -178.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 73.9 -34.35 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.33 -41.02 0.05 OUTLIER Glycine 0 C--N 1.31 -0.865 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.617 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -103.35 176.68 5.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.279 0.561 . . . . 0.0 111.349 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -130.3 164.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.866 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.68 -155.45 26.85 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.499 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 77.3 m95 -105.92 137.15 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.592 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.6 p90 -133.81 148.86 70.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 11.8 Cg_exo -71.7 129.12 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.57 2.18 . . . . 0.0 111.977 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.8 t -62.99 -11.71 20.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.996 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 54' ' ' ASN . 0.9 OUTLIER -69.42 -13.48 62.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.788 -177.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 72.4 m-85 -118.48 15.57 13.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -172.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG11 ' CE1' ' A' ' 51' ' ' PHE . 20.7 m -129.2 171.35 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.507 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.6 m -152.73 108.06 3.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.772 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 30.9 mt-10 -84.03 -71.87 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.732 0.777 . . . . 0.0 110.634 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -107.9 76.69 1.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.226 -174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.01 167.82 39.44 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.945 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.2 t -93.57 166.28 12.32 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 2' ' ' SER . 10.6 mp 69.14 23.0 6.59 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.6 0.714 . . . . 0.0 109.997 -173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -174.93 42.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.189 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 14.6 tpt -80.72 128.95 70.16 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.434 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.8 130.35 19.13 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.076 1.851 . . . . 0.0 111.191 173.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.66 128.2 26.66 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.011 0.434 . . . . 0.0 110.896 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.48 136.79 34.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.178 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.3 t -75.82 131.77 34.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.151 0.5 . . . . 0.0 111.387 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.821 ' HE2' ' HA ' ' A' ' 10' ' ' LYS . 5.9 mmpt? -82.78 -53.88 5.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.017 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 80.3 m-85 -129.11 160.6 32.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.715 -174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -72.6 107.16 4.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.056 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.9 t80 -110.15 100.54 9.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.938 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 38.6 ttm -81.25 106.85 13.55 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.066 0.46 . . . . 0.0 109.899 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -89.65 146.15 24.74 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.453 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.43 -12.46 9.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.55 0.214 . . . . 0.0 111.208 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 13.5 tpt180 -95.52 141.7 28.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.87 -23.29 64.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.095 0.474 . . . . 0.0 110.706 -176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.46 7.95 36.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.827 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 17' ' ' ARG . 55.7 mt-10 -99.78 169.45 9.24 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 170.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 HD23 ' A' ' 23' ' ' LEU . 1.3 tt -125.1 112.87 17.01 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -71.81 107.09 4.42 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.21 0.528 . . . . 0.0 109.691 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.9 mt -86.82 138.24 31.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.794 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -114.89 119.23 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.737 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -51.9 120.57 5.45 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.58 -10.45 28.14 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.267 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.6 p -105.45 176.27 5.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.294 0.547 . . . . 0.0 111.173 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 12.5 ttpt -133.47 129.11 36.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.74 170.18 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mm -110.56 108.11 24.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.464 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -87.9 114.54 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.795 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.468 ' HA ' ' C ' ' A' ' 3' ' ' LEU . 29.8 mtm -100.2 -54.47 2.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.146 0.498 . . . . 0.0 110.848 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 5.7 tp10 -110.5 141.71 43.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.821 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HE2' HG11 ' A' ' 31' ' ' VAL . 95.3 mttt -130.34 122.47 27.97 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.0 0.428 . . . . 0.0 112.102 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.1 m -98.63 102.3 13.99 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 164.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 m -51.9 -42.83 63.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.082 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -101.19 88.48 3.51 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.854 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.19 -127.74 4.11 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.323 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -96.51 146.39 24.84 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.199 0.523 . . . . 0.0 111.893 -172.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -104.79 142.53 34.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.791 171.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 65.2 ttt180 -101.86 105.78 16.65 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.791 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.14 164.2 24.22 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.65 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 48' ' ' VAL . 3.3 t -124.67 142.89 51.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.837 0.351 . . . . 0.0 110.072 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -136.85 126.47 25.34 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.3 t30 66.68 -90.92 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.83 0.706 . . . . 0.0 110.298 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.44 -3.26 3.09 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.014 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.05 128.53 47.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.6 p -108.37 159.27 7.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -160.98 34.1 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.934 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -106.22 142.27 36.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.067 0.46 . . . . 0.0 111.497 -174.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.5 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 47.8 p90 -143.66 150.14 49.48 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.319 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.702 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 24.0 Cg_exo -63.61 134.08 42.6 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.494 2.129 . . . . 0.0 111.752 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 p -63.18 -17.54 62.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 54' ' ' ASN . 1.0 OUTLIER -89.72 8.19 32.97 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.5 m-85 -114.38 16.53 17.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.579 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.85 169.51 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.535 0.683 . . . . 0.0 112.224 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -149.19 108.75 3.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.87 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.13 -78.07 0.05 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 0.0 110.596 -176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -137.56 88.63 2.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.726 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.36 -32.48 3.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.298 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.092 -177.531 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.991 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 p -96.68 -7.61 33.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 54.27 61.49 3.01 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.81 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -177.33 33.33 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.762 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.446 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 57.5 mtt -67.18 125.31 90.82 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.29 -175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 9.6 Cg_exo -72.33 128.99 14.31 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.705 2.27 . . . . 0.0 111.469 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.36 128.28 39.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.922 0.391 . . . . 0.0 110.71 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -80.25 147.14 31.33 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.3 t -85.09 128.74 38.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.221 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.0 mmmt -77.27 -53.94 7.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.623 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -133.19 160.99 35.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.436 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.54 109.69 4.4 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.486 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -114.4 99.8 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -89.39 100.34 13.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.205 0.526 . . . . 0.0 109.652 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -74.87 148.47 40.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.723 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -130.31 18.38 5.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.34 0.59 . . . . 0.0 110.393 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 21.4 mtp180 -134.56 147.57 50.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.365 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -64.87 -24.72 67.62 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.385 0.428 . . . . 0.0 111.244 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 9.7 p-10 -92.17 -1.17 57.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.857 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 49.7 mt-10 -99.23 170.83 8.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.602 177.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 44' ' ' TYR . 36.9 tp -129.01 122.09 29.32 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.2 t -81.55 124.84 29.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.047 0.451 . . . . 0.0 110.255 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 29' ' ' VAL . 52.6 mt -109.98 137.0 48.37 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.563 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.6 mm -113.64 116.97 54.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.002 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -52.14 120.63 5.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.46 -15.67 19.89 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.801 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.1 p -107.19 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.457 -0.437 . . . . 0.0 111.382 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 32.3 ttpt -138.65 136.05 35.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.189 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 23' ' ' LEU . 2.6 m -115.51 163.56 12.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.234 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mm -101.46 111.31 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.759 0.314 . . . . 0.0 110.503 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 47.0 t -94.88 108.9 21.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.1 0.476 . . . . 0.0 110.915 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 28.1 mtm -94.88 -65.29 0.99 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.186 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -103.89 134.77 46.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.088 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -135.57 137.67 42.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.024 0.44 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.6 m -100.23 144.03 29.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.7 m -61.64 -36.05 79.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.097 0.475 . . . . 0.0 110.919 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.77 136.97 51.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.596 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.48 -155.36 16.36 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.742 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.589 ' H ' ' HD1' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -109.51 160.61 16.08 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -106.0 166.09 10.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.251 -171.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -116.46 117.93 31.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.041 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.16 174.03 22.14 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.083 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.636 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.3 t -117.55 140.9 49.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.14 0.495 . . . . 0.0 110.669 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.588 ' HB3' HD11 ' A' ' 21' ' ' LEU . 39.0 t80 -140.5 147.87 40.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.963 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -37.77 103.69 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.895 0.747 . . . . 0.0 111.813 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.53 -50.91 0.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.333 -178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -165.68 -168.64 1.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.089 0.471 . . . . 0.0 111.194 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.9 p -128.33 161.15 37.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.73 -164.73 35.36 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.176 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -96.96 142.59 28.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.1 0.476 . . . . 0.0 111.408 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.491 ' O ' ' HB2' ' A' ' 39' ' ' TRP . 37.5 p90 -141.78 147.42 45.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.617 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 26.3 Cg_exo -62.39 132.66 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.096 . . . . 0.0 111.596 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 p -65.58 -11.78 47.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -85.54 -4.88 59.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.673 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 86.0 m-85 -105.24 11.69 32.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 m -129.86 151.03 35.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.454 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 17.8 m -115.46 103.18 10.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.657 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.14 -69.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.078 0.466 . . . . 0.0 110.149 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -169.45 102.35 0.34 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.33 55.13 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.364 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.38 -0.819 . . . . 0.0 109.882 178.266 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 m -145.2 81.74 1.64 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.114 0.483 . . . . 0.0 109.729 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.23 -49.19 62.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 50.9 54.11 11.82 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.613 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.2 mmm -77.56 123.46 86.7 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.129 -177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -77.95 128.77 9.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.473 2.115 . . . . 0.0 111.329 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -132.45 127.59 35.62 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.024 0.44 . . . . 0.0 110.895 -177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -78.92 143.81 35.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.353 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 87.4 t -83.12 128.65 38.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.084 0.469 . . . . 0.0 111.237 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.552 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 25.6 mmmt -78.59 -53.28 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.1 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.93 153.13 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.658 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -63.04 129.38 40.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.855 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.589 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 87.4 t80 -134.54 102.23 5.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.367 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -76.93 118.52 19.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.297 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.87 11.67 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.618 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.3 -19.22 50.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.646 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 1.7 mpt_? -84.77 137.36 33.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.243 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.89 -28.43 68.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 123.463 0.477 . . . . 0.0 112.052 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.32 -12.08 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 111.469 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -100.05 147.26 25.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.962 0.411 . . . . 0.0 110.044 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 44' ' ' TYR . 1.2 tm? -105.97 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.831 -172.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 p -71.52 135.37 47.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.116 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 67.7 mt -117.31 140.55 49.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.902 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.7 mm -120.74 119.07 58.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.767 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -55.74 121.28 8.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.36 -12.36 21.49 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.971 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -110.61 177.63 4.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 111.325 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.482 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 34.2 ttpt -129.98 134.02 47.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.723 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG11 HD22 ' A' ' 23' ' ' LEU . 2.7 m -108.69 169.67 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 120.415 0.15 . . . . 0.0 110.63 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.7 mm -116.1 108.3 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.428 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 16.4 t -88.85 111.4 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.838 0.351 . . . . 0.0 110.282 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.3 mtm -97.75 -29.59 13.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.988 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -135.42 123.85 23.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.032 0.444 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' HG11 ' A' ' 31' ' ' VAL . 92.3 mttt -108.34 144.82 35.35 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.5 m -121.3 135.36 55.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.502 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.0 m -75.47 1.26 14.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.452 0.644 . . . . 0.0 109.968 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.54 -34.44 75.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.759 176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.06 -64.29 0.33 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.703 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -102.44 162.03 13.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.681 0.277 . . . . 0.0 111.151 -177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -107.37 170.01 8.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 112.078 -171.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -118.86 106.89 12.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.647 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.93 171.18 23.97 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 48' ' ' VAL . 5.1 t -118.17 144.95 45.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.166 0.508 . . . . 0.0 111.425 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 21' ' ' LEU . 64.9 t80 -148.97 141.75 24.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.655 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.0 t30 66.18 -85.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.142 0.496 . . . . 0.0 110.986 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.58 17.69 0.76 Allowed Glycine 0 C--N 1.313 -0.749 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -126.05 131.27 52.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.6 p -106.08 157.25 6.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.53 -152.72 23.71 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.773 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -100.03 136.31 40.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.096 0.474 . . . . 0.0 111.954 -171.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.506 ' CE1' HG11 ' A' ' 56' ' ' VAL . 31.4 p90 -144.43 148.02 38.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.609 173.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 19.1 Cg_exo -66.14 125.69 14.51 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.439 2.093 . . . . 0.0 112.027 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 p -66.19 -12.25 54.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -63.46 -28.99 70.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.8 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -105.66 24.89 11.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG11 ' CE1' ' A' ' 51' ' ' PHE . 14.3 m -132.14 150.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.668 0.747 . . . . 0.0 112.87 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.552 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 10.8 m -129.22 106.12 8.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.817 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 43.5 mt-10 -65.29 -73.14 0.13 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.892 0.377 . . . . 0.0 111.901 -175.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -134.54 35.55 3.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.673 0.749 . . . . 0.0 109.841 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.43 125.85 2.74 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.534 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 C--O 1.244 0.775 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.381 177.247 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.274 -0.331 . . . . 0.0 112.274 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -139.05 23.97 2.57 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 122.535 -0.391 . . . . 0.0 111.407 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.8 tp -90.35 -55.88 3.42 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 58.58 68.54 0.81 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.018 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.48 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 23.0 ttt -109.07 128.17 25.93 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.208 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 6.8 Cg_exo -73.4 130.53 15.15 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.438 2.092 . . . . 0.0 112.018 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.81 134.45 37.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.181 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -85.99 139.54 31.1 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.584 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -78.28 134.18 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.889 0.376 . . . . 0.0 111.163 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -77.6 -55.69 5.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 86.9 m-85 -134.33 161.17 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.855 -174.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.25 113.06 7.91 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -105.52 101.15 10.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.654 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -74.55 84.04 2.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.809 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -89.77 98.08 11.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -92.54 2.47 56.67 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 20' ' ' GLU . 23.2 mtm105 -88.72 164.19 15.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.554 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -73.29 -35.87 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -172.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -101.98 1.64 36.89 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 53.2 mt-10 -99.05 150.92 21.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.1 tt -105.19 118.08 35.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.826 0.346 . . . . 0.0 110.308 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.7 p -69.74 102.17 1.85 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.609 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 51' ' ' PHE . 82.3 mt -87.13 143.48 27.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.208 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -114.6 117.22 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.205 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PHE . 76.3 tttt -54.28 120.9 7.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.81 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.17 -12.35 26.48 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.358 -0.925 . . . . 0.0 113.257 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.5 p -106.7 -177.36 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.222 0.511 . . . . 0.0 111.59 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 31.8 ttpt -130.7 136.81 49.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.627 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -114.76 164.83 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.374 . . . . 0.0 110.626 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 33.8 mm -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.251 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 4.8 t -77.44 100.41 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.924 0.392 . . . . 0.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 22.6 mtm -84.03 -36.69 22.94 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.088 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -137.59 135.11 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.233 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -125.03 161.63 26.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.575 0.703 . . . . 0.0 112.304 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.9 t -134.79 142.35 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.493 -1.23 . . . . 0.0 107.77 170.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.3 m -60.5 -39.22 86.94 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.99 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -135.8 114.37 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 137.61 -120.58 2.09 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.582 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -116.88 151.46 36.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -109.58 140.78 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.842 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -100.51 107.79 19.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.346 0.593 . . . . 0.0 109.913 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.69 172.15 18.95 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.239 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.611 ' HA ' HG23 ' A' ' 48' ' ' VAL . 4.9 p -122.38 138.66 54.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.034 0.445 . . . . 0.0 110.785 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 21' ' ' LEU . 29.2 t80 -132.87 148.36 52.3 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -59.61 102.72 0.16 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.924 0.392 . . . . 0.0 110.263 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.7 -38.03 2.93 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.707 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -143.2 150.05 38.82 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.957 0.408 . . . . 0.0 111.093 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 43' ' ' SER . 2.9 p -137.45 155.14 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 143.76 -149.29 21.28 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.724 -1.226 . . . . 0.0 112.984 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -95.91 144.68 26.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.912 0.387 . . . . 0.0 111.418 -175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 41.8 p90 -144.89 151.52 49.48 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.95 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.644 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 13.0 Cg_exo -71.01 133.68 23.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.719 2.279 . . . . 0.0 112.184 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.4 p -66.14 -20.18 66.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.402 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.13 -6.49 53.08 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.644 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 90.2 m-85 -113.33 18.86 17.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG11 ' CE1' ' A' ' 51' ' ' PHE . 5.4 m -128.85 148.94 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.408 0.623 . . . . 0.0 111.831 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.5 m -126.91 102.7 7.12 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.42 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 29.7 mt-10 -76.52 -74.86 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.253 0.549 . . . . 0.0 109.934 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -159.11 95.08 1.24 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.74 133.67 7.82 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -170.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.412 -0.804 . . . . 0.0 109.713 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -163.14 145.72 10.29 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.15 -63.19 1.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.107 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 57.1 31.1 19.4 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 76.2 mtp -87.41 122.94 70.46 Favored Pre-proline 0 N--CA 1.444 -0.769 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.55 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.578 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 14.5 Cg_exo -69.39 135.38 31.18 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.657 2.238 . . . . 0.0 111.544 176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.68 138.41 45.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -91.55 134.28 34.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.152 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 88.8 t -76.71 134.62 28.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 111.433 -176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 56' ' ' VAL . 94.7 mttt -83.56 -49.65 9.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.267 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -139.07 162.11 35.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.889 -175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.19 121.55 21.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.436 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -117.98 122.71 43.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.988 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 54.7 ttp -93.5 121.24 34.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.183 0.516 . . . . 0.0 110.624 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -94.54 154.83 17.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.43 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -129.41 -46.17 1.2 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.093 0.473 . . . . 0.0 110.503 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 14.3 mmt85 -70.95 160.52 32.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.898 -176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.03 -24.78 65.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.854 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.49 10.95 36.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.622 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 26.4 mt-10 -94.3 151.95 19.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.889 0.376 . . . . 0.0 110.674 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tm? -125.56 118.5 25.87 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.972 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.03 143.56 43.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.403 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 76.4 mt -124.14 146.81 48.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -175.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 44.8 mm -127.24 123.89 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.991 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.13 121.19 7.62 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.43 -21.37 21.81 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.964 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -94.39 178.74 5.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.105 0.478 . . . . 0.0 111.447 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.578 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 22.7 ttpt -133.16 131.85 40.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.385 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 HD22 ' A' ' 23' ' ' LEU . 3.7 m -111.65 167.01 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.247 178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -106.74 106.46 20.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.49 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 38.6 t -84.7 102.92 11.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.818 0.342 . . . . 0.0 110.338 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 29.4 mtm -83.79 -42.07 16.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.772 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -137.23 150.84 48.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.65 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -130.33 117.61 20.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.665 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 t -95.52 156.79 16.17 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.004 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.0 m -83.93 -4.0 58.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.247 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -82.73 -35.53 26.57 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.27 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.73 -35.9 1.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.03 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -77.43 126.03 30.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.954 0.407 . . . . 0.0 111.017 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -106.36 146.9 29.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.209 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -97.15 106.78 19.17 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.636 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.59 170.77 24.06 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.329 -0.938 . . . . 0.0 113.342 -173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' HB3' HG23 ' A' ' 48' ' ' VAL . 84.5 p -125.56 144.75 50.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.303 . . . . 0.0 110.229 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.487 ' HB3' HD21 ' A' ' 21' ' ' LEU . 55.5 t80 -151.82 133.93 15.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.768 0.318 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 65.05 -86.24 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.736 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.43 20.24 1.05 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.016 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -141.51 150.53 42.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.4 p -121.03 163.28 18.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.01 -145.66 11.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.474 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -112.9 143.62 43.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.862 0.363 . . . . 0.0 110.822 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.508 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 45.9 p90 -138.93 154.83 73.03 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.944 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.45 130.17 18.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.471 2.114 . . . . 0.0 112.293 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.6 p -63.49 -26.4 68.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.461 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -62.35 -29.87 70.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.7 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -89.83 10.84 22.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' O ' ' HE3' ' A' ' 10' ' ' LYS . 21.4 m -133.1 150.25 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -122.66 130.42 52.95 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.154 173.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.07 -70.33 0.19 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.376 0.608 . . . . 0.0 110.247 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -160.85 26.71 0.14 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.922 0.867 . . . . 0.0 108.981 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.71 -40.04 0.3 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.443 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.139 -0.934 . . . . 0.0 108.865 173.521 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 m -131.25 174.23 10.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -89.22 -45.15 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.762 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 59.5 69.21 0.73 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.585 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.71 119.23 56.44 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.41 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.534 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 25.7 Cg_exo -63.32 132.14 34.9 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.681 2.254 . . . . 0.0 112.073 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -133.57 129.84 37.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.979 0.418 . . . . 0.0 110.276 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -81.61 130.9 35.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.663 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 96.0 t -74.94 129.03 37.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.46 ' HD3' ' OG1' ' A' ' 57' ' ' THR . 27.2 mtmm -90.46 -39.45 12.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.604 -178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.611 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 84.7 m-85 -135.38 152.55 51.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.73 0.3 . . . . 0.0 111.044 -175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -72.88 98.08 2.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -89.28 102.68 15.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.3 ttt -81.07 93.61 6.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.179 0.514 . . . . 0.0 110.163 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB1' ' CB ' ' A' ' 20' ' ' GLU . . . -76.18 155.52 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.595 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -117.25 -48.74 2.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 0.0 110.605 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' HB3' ' OD1' ' A' ' 19' ' ' ASP . 16.8 mtp180 -74.37 147.19 42.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.202 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -73.09 -11.9 60.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.166 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 17' ' ' ARG . 8.5 p-10 -92.91 -2.52 55.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.433 0.635 . . . . 0.0 110.168 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 40.9 mt-10 -88.77 170.24 10.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.317 170.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -122.33 111.5 16.97 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.214 177.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.2 p -72.75 118.07 15.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.162 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 79.4 mt -104.39 145.16 30.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.987 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.5 mm -125.36 120.97 59.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.939 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -56.22 121.11 8.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.77 -12.73 24.97 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.538 -176.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -106.92 -174.67 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.937 0.369 . . . . 0.0 111.171 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 29.5 ttpt -143.73 135.45 26.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.58 -174.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -113.91 164.31 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.376 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.665 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 21.8 mm -108.38 103.79 16.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.537 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.5 t -80.84 100.98 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.962 0.41 . . . . 0.0 110.441 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.9 mtm -85.61 -39.5 17.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -134.49 140.92 46.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.001 -176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -125.51 150.13 47.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.942 0.401 . . . . 0.0 110.832 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -122.84 149.53 44.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.825 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -79.54 1.42 25.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.878 0.371 . . . . 0.0 111.612 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.83 0.75 52.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.212 0.53 . . . . 0.0 111.046 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 110.07 -22.12 23.68 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.877 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -88.02 129.57 35.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.965 0.412 . . . . 0.0 111.279 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -117.17 141.34 48.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.83 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -96.67 105.8 17.97 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.63 158.47 15.6 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.452 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.665 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 66.9 p -109.16 140.16 43.11 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.558 ' HB3' HD21 ' A' ' 21' ' ' LEU . 76.8 t80 -135.54 109.74 8.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.671 0.272 . . . . 0.0 110.564 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.2 t30 63.92 -79.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.222 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.24 -18.21 1.69 Allowed Glycine 0 C--N 1.312 -0.797 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.429 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -98.96 165.51 11.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.646 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.3 p -138.52 161.75 30.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.69 -161.46 33.75 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 119.584 -1.293 . . . . 0.0 113.243 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -103.32 138.01 40.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.859 0.361 . . . . 0.0 111.265 -174.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 45.2 p90 -141.16 151.03 60.68 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.86 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.43 127.01 12.77 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.838 2.359 . . . . 0.0 111.616 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.6 p -56.24 -26.0 49.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.534 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -55.15 -32.07 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 77.3 m-85 -89.0 7.43 34.81 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.47 163.02 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.46 ' OG1' ' HD3' ' A' ' 10' ' ' LYS . 1.3 m -130.42 119.09 22.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.164 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.45 -87.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.753 0.311 . . . . 0.0 111.055 -177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -146.47 96.97 2.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.5 107.53 0.21 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.84 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 170.532 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -126.51 -2.7 6.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.098 0.475 . . . . 0.0 110.742 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 32' ' ' MET . 11.1 mp -109.72 66.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.929 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -175.62 31.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.16 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.0 tpt -72.42 120.46 80.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.458 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.08 130.76 18.22 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.153 1.902 . . . . 0.0 111.887 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 135.22 38.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.816 0.341 . . . . 0.0 110.589 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -91.3 128.58 37.18 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.18 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 98.4 t -65.76 132.32 31.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 0.0 112.161 -174.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HE2' ' OG1' ' A' ' 57' ' ' THR . 21.2 mmtt -74.13 -58.8 3.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.798 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.1 164.89 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.429 -174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.26 100.15 2.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.107 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 88.1 t80 -102.0 100.59 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.0 ptp -85.09 103.14 13.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.466 0.65 . . . . 0.0 110.409 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 20' ' ' GLU . . . -82.55 157.86 23.35 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.046 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -132.12 -32.29 1.41 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.839 0.352 . . . . 0.0 111.26 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 23.4 mtp180 -80.15 154.86 27.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.25 0.548 . . . . 0.0 111.326 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -63.97 -32.54 74.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.011 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.66 9.03 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.198 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 71.5 mt-10 -106.77 162.73 13.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.877 0.37 . . . . 0.0 110.671 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.7 tm? -127.4 120.84 29.36 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.9 p -81.79 141.85 33.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.213 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 29' ' ' VAL . 65.1 mt -122.24 143.86 49.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.086 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -123.84 124.22 68.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.615 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -56.93 121.12 9.19 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.38 -26.97 9.25 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.753 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -94.02 170.94 9.17 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 111.681 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 24.5 ttpt -122.58 134.39 54.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.357 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -111.72 171.34 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.661 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 26.0 mm -113.9 107.62 23.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.364 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 21.3 t -86.27 115.93 28.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.304 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.411 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 30.7 mtm -94.68 -72.32 0.62 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.815 0.34 . . . . 0.0 110.346 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -104.48 138.33 41.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.278 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -115.68 115.13 25.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.258 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 t -86.7 138.24 31.8 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 m -72.96 0.82 10.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.067 0.461 . . . . 0.0 111.38 -174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -99.55 10.04 42.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.431 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.84 -27.46 13.08 Favored Glycine 0 C--O 1.235 0.177 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.173 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -90.12 126.6 35.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.09 0.471 . . . . 0.0 111.303 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.3 m0 -111.33 137.03 49.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.949 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -89.45 105.79 18.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 21' ' ' LEU . . . -125.5 156.0 19.11 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.391 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 88.0 p -112.13 131.42 55.46 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.6 t80 -140.59 137.34 33.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.884 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 t30 63.58 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.063 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.24 11.07 1.36 Allowed Glycine 0 C--N 1.313 -0.73 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.421 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -125.04 154.56 41.11 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 43' ' ' SER . 0.9 OUTLIER -125.22 164.07 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.12 -155.01 26.11 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.118 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -110.41 134.03 52.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.86 0.362 . . . . 0.0 110.957 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 28.5 p90 -128.22 154.47 78.86 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.669 176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 9.1 Cg_exo -72.98 132.71 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.629 2.219 . . . . 0.0 112.04 177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.6 t -58.04 -22.05 48.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.526 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -79.98 15.92 1.34 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 85.1 m-85 -131.83 18.82 4.63 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -135.21 136.09 51.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' ' HE2' ' A' ' 10' ' ' LYS . 3.3 m -107.04 106.31 16.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.129 170.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.15 -70.87 0.36 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.356 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -157.76 98.11 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.434 0.635 . . . . 0.0 110.064 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.43 -49.77 0.82 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.106 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.595 -177.582 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.816 0 N-CA-C 112.703 -0.159 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -79.13 50.33 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.117 0.484 . . . . 0.0 112.085 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.6 mt -98.33 144.21 27.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 63.21 44.13 5.87 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.237 0.541 . . . . 0.0 109.633 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.1 tpt -75.38 119.26 76.17 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.143 -174.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 2.6 Cg_exo -75.49 125.63 9.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.699 2.266 . . . . 0.0 111.216 175.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -141.2 145.85 36.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.73 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.0 m-85 -87.66 133.85 33.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.715 -174.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 94.0 t -66.1 128.02 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.065 0.459 . . . . 0.0 111.696 -177.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -67.87 -62.04 1.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -137.11 159.19 42.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.167 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -66.71 131.45 46.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.223 0.535 . . . . 0.0 110.638 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 22' ' ' SER . 80.4 t80 -124.77 110.88 14.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.028 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 tpt -83.5 113.24 20.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.062 0.458 . . . . 0.0 110.317 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.54 28.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.236 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.37 28.88 7.89 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.261 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' HG2' ' OD1' ' A' ' 19' ' ' ASP . 15.6 ttm-85 -145.75 151.92 38.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.642 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' OE1' ' HG3' ' A' ' 17' ' ' ARG . 2.0 mp0 -67.84 -33.36 74.62 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -170.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' HG2' ' A' ' 17' ' ' ARG . 6.6 p-10 -83.2 4.98 24.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.066 0.46 . . . . 0.0 110.959 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -113.28 153.61 28.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.327 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.9 tt -116.58 119.49 35.72 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.9 t -79.58 113.66 17.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.014 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.68 HD22 HG11 ' A' ' 29' ' ' VAL . 73.9 mt -94.24 151.35 19.51 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.121 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 42.0 mm -124.57 122.66 64.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.916 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -55.47 121.25 8.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -23.59 12.91 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.657 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 79.9 p -93.28 -179.02 4.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.998 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -134.56 136.63 43.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.246 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.68 HG11 HD22 ' A' ' 23' ' ' LEU . 3.1 m -117.81 165.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.725 0.298 . . . . 0.0 110.93 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.6 mm -105.46 105.22 18.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 13.8 t -82.25 103.08 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.459 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 34.0 mtm -81.98 -39.04 24.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.497 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -140.94 141.57 34.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.64 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 94.3 mttt -126.11 121.14 32.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.492 -179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.4 m -115.66 151.12 35.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.641 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 m -70.81 -4.39 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.844 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.85 -19.92 65.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.937 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.18 -10.7 58.37 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 -177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -99.04 121.62 41.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.126 -0.537 . . . . 0.0 109.998 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.523 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 49.2 m0 -105.61 142.97 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.766 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -97.59 106.12 18.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -125.28 171.36 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.982 -174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.576 ' HB3' HG23 ' A' ' 48' ' ' VAL . 19.7 p -130.6 139.17 50.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 48.3 t80 -146.58 113.85 6.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.755 0.312 . . . . 0.0 111.223 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.6 t30 61.4 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.214 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.48 -1.58 10.01 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -101.82 139.99 36.71 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.8 p -138.46 152.9 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.78 -145.11 13.11 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 119.658 -1.258 . . . . 0.0 113.032 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -102.58 141.57 35.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.498 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 36.7 p90 -140.99 150.09 58.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 172.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 14.4 Cg_exo -70.15 139.63 39.31 Favored 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 122.444 2.096 . . . . 0.0 111.844 177.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 p -57.47 -27.32 62.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -80.97 19.19 0.9 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -175.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 66.3 m-85 -124.91 10.71 8.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -129.45 170.59 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 81.3 m -147.23 101.59 3.41 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.837 -172.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 18.9 mp0 -83.38 -73.27 0.42 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -111.74 74.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.399 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.89 177.36 26.58 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.8 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.82 177.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -140.25 130.89 25.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.931 0.365 . . . . 0.0 110.44 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 3' ' ' LEU . 4.2 mm? -74.41 176.65 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 62.5 44.47 7.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.37 0.605 . . . . 0.0 109.408 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 52.9 mtt -66.49 127.47 93.36 Favored Pre-proline 0 N--CA 1.445 -0.707 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.699 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.601 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 3.4 Cg_exo -76.83 135.5 15.88 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.572 2.182 . . . . 0.0 111.607 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.58 129.04 34.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.04 0.448 . . . . 0.0 110.538 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -80.75 128.55 33.77 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.173 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 88.6 t -72.84 130.95 35.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.975 0.417 . . . . 0.0 110.79 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.874 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 7.0 mmpt? -90.78 -41.68 11.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.917 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB2' ' CD2' ' A' ' 55' ' ' TYR . 81.2 m-85 -135.66 154.68 51.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.712 0.292 . . . . 0.0 110.586 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -71.09 126.38 29.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.848 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -130.96 114.98 15.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.852 0.358 . . . . 0.0 110.37 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.2 mtt -90.45 122.25 33.13 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.75 124.69 36.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.547 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -108.78 -39.84 5.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.88 0.371 . . . . 0.0 110.733 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 49.8 mtt85 -78.07 161.47 27.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.925 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.59 -34.41 78.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.22 10.37 29.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.601 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 35.7 mt-10 -95.78 152.42 18.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.105 0.479 . . . . 0.0 111.318 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.97 122.34 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.216 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.0 p -75.45 137.77 41.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.572 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD22 HG11 ' A' ' 29' ' ' VAL . 56.6 mt -120.87 144.33 48.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.44 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mm -121.9 118.88 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 24.0 ttpp -53.9 121.17 7.42 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.83 -19.92 18.01 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.697 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.8 p -101.4 -174.06 2.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.409 . . . . 0.0 111.943 -176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.601 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 20.5 ttpt -135.95 136.04 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.374 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 23' ' ' LEU . 5.3 m -113.48 165.14 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.748 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -108.51 107.25 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.612 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.8 t -88.81 119.54 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 30.7 mtm -109.16 -14.07 14.56 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.904 0.383 . . . . 0.0 111.277 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 38.6 tt0 -148.9 133.09 17.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.858 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -126.63 125.84 42.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.04 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.27 110.72 22.98 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 p -67.5 0.84 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -129.33 8.3 5.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.845 -0.162 . . . . 0.0 111.43 -177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.99 -118.79 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 119.469 -1.348 . . . . 0.0 114.128 -176.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -86.95 160.67 18.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.085 0.469 . . . . 0.0 111.521 -171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -114.3 143.3 45.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.044 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 9.6 ttp180 -103.72 111.23 23.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.427 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.87 169.68 24.57 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.947 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB2' HG23 ' A' ' 48' ' ' VAL . 7.8 t -115.73 133.33 56.13 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.226 0.536 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -118.1 117.12 28.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.471 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.0 t30 64.46 -91.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.787 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.19 7.3 8.09 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.534 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -134.15 154.91 50.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.238 0.519 . . . . 0.0 110.657 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 43' ' ' SER . 2.4 p -119.46 165.77 14.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.06 -163.1 33.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.283 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -97.41 131.71 43.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.837 0.351 . . . . 0.0 110.939 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' A' ' 56' ' ' VAL . 41.0 p90 -130.08 149.87 74.41 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.626 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 21.0 Cg_exo -66.45 133.18 31.48 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.445 2.097 . . . . 0.0 111.822 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -66.43 -22.03 66.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.499 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -77.52 -2.52 35.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.163 0.506 . . . . 0.0 111.32 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.626 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 47.2 m-85 -107.56 9.7 29.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG21 ' HE1' ' A' ' 51' ' ' PHE . 17.4 m -134.61 172.67 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.611 0.72 . . . . 0.0 112.666 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 m -142.85 119.21 10.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.2 -89.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 110.799 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -128.7 82.17 2.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.66 -167.42 11.22 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.849 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.531 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 p -149.09 160.05 43.68 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.727 -0.278 . . . . 0.0 110.373 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -85.84 -36.1 20.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.865 0.364 . . . . 0.0 110.57 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 56.83 58.17 4.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.641 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 65.2 mtt -91.11 122.12 66.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.263 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.538 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 16.3 Cg_exo -67.65 126.53 14.89 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.192 1.928 . . . . 0.0 111.424 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -128.04 128.3 44.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.158 0.504 . . . . 0.0 110.869 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.92 131.09 35.2 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.941 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 93.7 t -72.82 122.4 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.123 0.487 . . . . 0.0 110.314 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 18.3 mtmm -81.92 -42.29 19.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.736 -175.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.728 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 49.2 m-85 -134.86 148.55 50.16 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -68.24 129.63 40.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.185 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.548 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 74.7 t80 -127.87 110.4 12.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.025 -173.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.6 mmt -85.8 122.27 29.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.508 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.82 114.71 18.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.403 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -105.7 -26.5 11.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.479 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.415 ' HE ' ' CD ' ' A' ' 20' ' ' GLU . 79.8 mtm180 -97.97 170.45 8.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.907 177.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.23 -27.24 60.68 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.357 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -93.86 -5.05 48.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.471 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.415 ' CD ' ' HE ' ' A' ' 17' ' ' ARG . 59.1 mt-10 -89.21 146.72 24.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.111 0.481 . . . . 0.0 111.436 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 44' ' ' TYR . 2.3 tt -106.65 130.41 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.467 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.424 ' N ' HD23 ' A' ' 21' ' ' LEU . 24.8 p -73.64 113.86 11.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.912 0.387 . . . . 0.0 110.783 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 13' ' ' TYR . 78.1 mt -106.25 148.85 27.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.742 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 47.0 mm -127.64 120.91 55.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.171 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.559 ' HE2' ' O ' ' A' ' 10' ' ' LYS . 38.7 ttmt -53.68 120.79 6.68 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.59 -21.18 17.13 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.797 -177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.8 p -96.26 -179.42 4.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 117.036 0.418 . . . . 0.0 111.066 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.9 ttmt -135.77 136.97 41.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.347 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -114.77 158.47 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 31.4 mm -97.67 100.33 10.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.197 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 43.6 t -76.83 99.38 2.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.361 0.6 . . . . 0.0 109.802 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.3 mtm -81.27 -40.61 23.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -143.4 136.34 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.677 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.628 ' HD2' ' CE2' ' A' ' 40' ' ' TRP . 45.2 mtmt -121.85 107.63 12.52 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.9 p -80.72 -169.5 2.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.837 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.2 p -80.74 1.55 29.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.955 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.0 -165.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.77 -7.93 57.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.873 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -88.68 114.88 25.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.063 0.459 . . . . 0.0 110.289 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.628 ' CE2' ' HD2' ' A' ' 34' ' ' LYS . 47.2 m0 -98.16 150.65 21.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.129 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 41' ' ' ARG . 43.6 ttp85 -106.61 106.01 16.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 109.889 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -129.33 172.07 19.9 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.301 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 16.3 p -123.32 128.01 49.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.882 0.372 . . . . 0.0 110.897 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.549 ' HB3' HD21 ' A' ' 21' ' ' LEU . 70.7 t80 -108.19 148.4 29.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -47.66 95.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.347 0.404 . . . . 0.0 111.354 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.39 -47.39 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.919 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -142.04 179.63 6.78 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 117.189 0.495 . . . . 0.0 111.241 -174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.2 p -138.6 165.27 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -161.34 31.01 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.229 174.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -98.67 152.25 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.113 0.482 . . . . 0.0 110.91 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.59 ' HE1' HG21 ' A' ' 56' ' ' VAL . 46.7 p90 -151.91 150.06 25.08 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.819 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.72 138.36 23.66 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.487 2.125 . . . . 0.0 111.968 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.2 t -58.16 -20.64 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.867 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.6 -29.38 69.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.907 -177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.728 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 99.4 m-85 -104.66 10.97 34.62 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG21 ' HE1' ' A' ' 51' ' ' PHE . 26.7 m -129.79 167.51 24.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.546 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -153.77 107.84 3.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.7 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.3 mp0 -62.28 -75.4 0.07 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.101 0.477 . . . . 0.0 110.728 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.4 84.68 2.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.83 151.3 44.5 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.92 -174.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.466 179.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 32' ' ' MET . 16.3 m -70.97 164.27 25.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.973 0.415 . . . . 0.0 110.733 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.22 -41.17 42.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.878 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 32' ' ' MET . 53.1 m-80 65.33 85.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.537 0.523 . . . . 0.0 111.006 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.562 ' HE2' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -112.8 118.97 43.97 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.155 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD2' ' HE2' ' A' ' 5' ' ' MET . 15.3 Cg_exo -69.2 131.36 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.471 2.114 . . . . 0.0 111.858 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -142.4 145.65 34.06 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.853 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 14.6 m-85 -83.23 160.76 21.7 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.984 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.49 136.47 23.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.066 0.46 . . . . 0.0 111.695 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -74.58 -58.91 2.99 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.875 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -136.4 159.08 42.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.109 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -68.86 122.38 18.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.503 0.668 . . . . 0.0 110.239 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' SER . 79.3 t80 -131.14 100.03 5.07 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.879 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.41 111.55 20.62 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -177.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HB3' HE22 ' A' ' 47' ' ' GLN . . . -78.47 130.23 35.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.062 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -101.25 -32.59 10.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.9 mtm105 -92.53 167.31 12.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.272 0.558 . . . . 0.0 111.973 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.75 -35.85 75.3 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.923 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.99 24.64 6.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.096 0.474 . . . . 0.0 111.393 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -111.8 167.83 10.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.919 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.7 OUTLIER -130.93 127.81 39.21 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 5.5 m -77.53 117.66 19.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 0.0 110.401 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 29' ' ' VAL . 41.4 mt -105.73 145.87 30.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.853 -177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.9 mm -124.7 119.24 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.214 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -54.75 121.82 9.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.11 -23.58 11.34 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.575 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.3 p -100.95 178.25 4.73 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.703 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 29.6 ttmt -128.94 133.31 47.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.094 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD22 ' A' ' 23' ' ' LEU . 3.6 m -108.89 166.55 4.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.944 0.402 . . . . 0.0 110.801 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.2 mm -105.95 109.54 28.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.976 176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.4 t -84.18 94.6 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.497 ' O ' ' HB3' ' A' ' 2' ' ' SER . 39.2 mtm -63.52 -61.17 2.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.103 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -135.61 147.81 48.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.907 -174.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -121.7 161.57 22.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 0.0 111.23 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.7 p -129.56 -175.83 3.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.769 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.5 p -91.78 -33.42 14.99 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -70.81 -38.38 73.28 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.12 -29.73 1.92 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 119.804 -1.188 . . . . 0.0 113.913 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -74.19 107.9 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.561 0.681 . . . . 0.0 111.185 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -97.22 138.47 34.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.063 0.458 . . . . 0.0 111.186 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -82.66 105.59 13.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.168 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 165.3 21.16 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.448 -172.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.529 ' HB3' HG23 ' A' ' 48' ' ' VAL . 16.5 p -134.74 136.78 42.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.068 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.596 ' HB3' HD21 ' A' ' 21' ' ' LEU . 50.0 t80 -144.44 112.89 6.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 111.588 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.3 t30 64.31 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.783 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.14 3.98 5.24 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.26 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.42 HE22 ' HB3' ' A' ' 15' ' ' ALA . 51.5 tt0 -118.31 135.74 54.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -126.29 161.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.69 -136.35 5.7 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.682 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.1 m95 -122.74 146.91 47.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.726 0.298 . . . . 0.0 110.397 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.554 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 31.6 p90 -139.31 154.93 72.37 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.087 177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 15.0 Cg_exo -69.65 130.29 19.21 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.519 2.146 . . . . 0.0 111.621 174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 p -62.04 -19.2 62.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 54' ' ' ASN . 2.3 t-20 -87.84 0.84 55.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.952 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 m-85 -101.97 3.87 39.4 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.234 -0.291 . . . . 0.0 111.53 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 m -114.82 171.74 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.085 0.469 . . . . 0.0 111.286 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 85.3 m -138.04 102.38 4.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.358 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 36.0 mt-10 -92.17 -65.03 1.04 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 4.2 mm-40 -167.71 106.46 0.54 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.926 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.75 22.76 74.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.386 172.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.767 178.612 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.081 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.0 p 54.82 174.41 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.482 1.113 . . . . 0.0 112.324 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 32' ' ' MET . 3.5 mm? -84.93 171.73 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.363 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 178.58 69.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.854 0.722 . . . . 0.0 109.332 -169.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.2 tpt -96.5 119.0 64.84 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.335 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 15.2 Cg_exo -67.61 134.44 32.88 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.151 1.901 . . . . 0.0 111.202 177.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 56' ' ' VAL . . . -135.94 127.68 29.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.042 0.449 . . . . 0.0 110.886 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -87.4 131.63 34.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.743 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.95 129.62 35.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.865 0.364 . . . . 0.0 111.352 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 56' ' ' VAL . 56.6 mttm -76.39 -55.93 5.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.145 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.04 161.19 35.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.07 -173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -68.7 125.66 27.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.381 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -135.72 108.84 7.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 110.672 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -77.55 136.21 38.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.239 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.83 136.13 48.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.63 -46.42 4.35 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.889 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -96.77 159.09 15.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.563 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.63 -13.71 61.05 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 6.5 p-10 -86.23 9.11 18.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.801 173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -113.76 168.69 9.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.088 170.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD21 ' HB3' ' A' ' 44' ' ' TYR . 0.5 OUTLIER -135.26 125.4 26.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 175.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.8 p -69.67 109.02 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.419 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 62.2 mt -103.55 139.31 39.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.609 -177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -122.89 119.53 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -54.99 122.04 10.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.2 -14.44 18.74 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.185 -175.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -108.37 177.71 4.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.052 0.453 . . . . 0.0 111.585 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 23.7 ttpt -134.74 134.46 41.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.472 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.3 172.47 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.582 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.591 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 23.3 mm -115.89 108.6 25.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.791 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 19.8 t -91.37 109.78 21.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.376 . . . . 0.0 110.752 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 29.9 mtm -99.95 -25.72 14.23 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.238 -177.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 41' ' ' ARG . 14.2 mm-40 -134.46 127.28 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.221 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 53.5 mtpt -118.2 126.87 53.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.391 -175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -90.88 171.3 9.4 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 m -64.01 -44.29 93.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -148.28 -27.93 0.32 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.74 -128.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.968 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -80.34 142.97 33.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.012 0.434 . . . . 0.0 111.099 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.732 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 19.7 m0 -106.94 145.09 32.65 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.197 175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.628 ' HB3' ' HB2' ' A' ' 33' ' ' GLU . 38.3 ttt180 -98.58 109.37 22.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' HA3' ' HE2' ' A' ' 51' ' ' PHE . . . -139.86 172.12 23.52 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.968 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.591 ' HB3' HG23 ' A' ' 48' ' ' VAL . 89.9 p -122.51 142.96 50.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.632 -0.284 . . . . 0.0 110.428 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' HB3' HD21 ' A' ' 21' ' ' LEU . 38.6 t80 -139.5 111.02 7.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.866 0.365 . . . . 0.0 110.417 177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 62.19 -93.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.904 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -115.26 -17.59 6.62 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.94 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -103.57 133.81 47.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.286 0.565 . . . . 0.0 110.895 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.7 p -112.64 161.4 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.019 175.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 157.85 -142.07 8.25 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 119.785 -1.198 . . . . 0.0 112.727 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 69.9 m95 -119.52 147.32 44.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.904 0.383 . . . . 0.0 110.635 -175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' CE1' HG11 ' A' ' 56' ' ' VAL . 34.2 p90 -144.42 155.31 57.41 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.908 177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 13.5 Cg_exo -70.15 129.57 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.52 2.147 . . . . 0.0 111.622 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 p -63.69 -16.16 60.32 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.154 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -70.5 -14.48 62.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 111.091 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.552 ' HD1' ' HB2' ' A' ' 52' ' ' PRO . 79.7 m-85 -105.6 13.17 30.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -174.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 51' ' ' PHE . 12.6 m -133.16 150.62 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.5 m -122.53 107.29 11.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.225 174.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.43 -80.46 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -134.02 84.69 2.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.539 . . . . 0.0 110.421 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.83 -140.47 4.04 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.801 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.397 -178.03 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.106 -0.397 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 m -121.38 9.48 10.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.13 0.49 . . . . 0.0 110.325 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 4' ' ' ASN . 1.5 tt -100.66 133.91 44.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.256 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' HG2' ' A' ' 32' ' ' MET . 95.6 m-20 67.09 51.22 0.95 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.742 0.652 . . . . 0.0 110.59 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.436 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.1 tpt -95.94 122.44 58.42 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.377 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 5.2 Cg_exo -76.96 128.74 10.15 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.728 2.286 . . . . 0.0 111.607 177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.618 ' HB2' ' HG2' ' A' ' 58' ' ' GLU . . . -136.61 136.69 39.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.608 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 11.1 m-85 -87.84 119.11 27.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.549 -175.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.2 t -59.34 122.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.806 0.336 . . . . 0.0 111.081 -177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.57 -34.05 25.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.073 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.67 146.11 32.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.728 -173.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -70.03 97.01 1.1 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.729 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 23' ' ' LEU . 77.3 t80 -94.12 99.11 11.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.5 tpt -86.81 101.32 13.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.035 0.445 . . . . 0.0 110.217 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 20' ' ' GLU . . . -66.19 143.74 57.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.646 -177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.85 -29.42 5.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.036 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HB2' ' HG3' ' A' ' 20' ' ' GLU . 18.2 mtp180 -78.97 156.67 28.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.93 -29.8 62.22 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.365 0.602 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -86.96 -6.03 58.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.319 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.682 ' HG3' ' HB2' ' A' ' 17' ' ' ARG . 54.5 mt-10 -83.19 169.67 15.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.954 176.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.4 tt -123.81 123.23 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.678 176.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.0 p -73.55 111.06 8.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.942 0.401 . . . . 0.0 110.622 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD22 HG11 ' A' ' 29' ' ' VAL . 82.1 mt -100.62 140.16 35.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.813 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -115.25 116.32 52.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.844 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -52.95 120.79 6.24 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.23 -26.37 8.26 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.623 -175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 80.5 p -95.81 178.54 5.41 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.609 -0.347 . . . . 0.0 111.567 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -129.5 135.28 48.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.187 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG11 HD22 ' A' ' 23' ' ' LEU . 3.8 m -114.41 163.93 11.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.2 mm -107.21 104.14 16.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.95 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG11 ' HE2' ' A' ' 34' ' ' LYS . 9.2 t -79.91 105.75 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.473 ' HG2' ' OD1' ' A' ' 4' ' ' ASN . 26.6 mtm -89.51 -60.21 2.01 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.951 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -114.19 124.07 51.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HE2' HG11 ' A' ' 31' ' ' VAL . 91.8 mttt -112.31 131.34 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.75 -176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.86 167.6 14.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.885 0.374 . . . . 0.0 110.054 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 p -76.91 -1.7 29.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -113.28 -82.16 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.775 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.36 -20.52 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.219 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -76.44 113.31 13.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.427 ' O ' ' HA ' ' A' ' 50' ' ' TRP . 42.0 m0 -109.59 136.33 49.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.066 176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -98.63 105.21 17.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.497 0.665 . . . . 0.0 109.396 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.71 170.9 14.96 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.236 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.63 ' HB2' HG23 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -121.04 128.08 52.32 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.41 0.624 . . . . 0.0 110.956 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.605 ' HB3' HD21 ' A' ' 21' ' ' LEU . 68.2 t80 -109.58 147.86 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.04 96.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.458 . . . . 0.0 110.373 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.01 -44.87 1.11 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.244 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -151.03 144.78 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.308 0.575 . . . . 0.0 111.685 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 43' ' ' SER . 4.2 p -108.99 160.44 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 156.93 -163.95 32.51 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.47 -1.348 . . . . 0.0 112.975 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 75.8 m95 -96.94 140.6 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -173.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.474 ' HZ ' HG22 ' A' ' 31' ' ' VAL . 32.2 p90 -146.8 150.6 39.93 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.625 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 15.6 Cg_exo -70.19 136.62 32.29 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.744 2.296 . . . . 0.0 112.355 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.3 m -54.12 -40.36 67.26 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -78.01 19.58 0.41 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -116.33 5.08 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.695 -0.628 . . . . 0.0 111.185 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.61 166.06 26.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.047 0.451 . . . . 0.0 111.517 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 8' ' ' TYR . 93.1 m -114.65 102.25 9.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 7' ' ' ALA . 38.6 mt-10 -93.64 -67.36 0.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.606 0.717 . . . . 0.0 109.458 174.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -148.7 93.39 2.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.132 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.41 24.96 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.22 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.625 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -83.87 81.57 8.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.627 0.251 . . . . 0.0 111.152 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp 69.03 -67.18 0.22 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.436 0.695 . . . . 0.0 111.341 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 56.4 48.1 17.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.046 0.451 . . . . 0.0 110.516 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.9 ttt -86.29 119.28 71.47 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.417 -175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' LYS . 64.1 Cg_endo -77.52 134.82 14.16 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.129 1.886 . . . . 0.0 112.467 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.62 134.95 41.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -93.77 124.33 37.71 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.029 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 24' ' ' ILE . 59.4 t -65.82 131.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.995 0.426 . . . . 0.0 111.45 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -87.25 -35.41 18.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.303 -177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 150.26 31.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.748 -172.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.87 87.18 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.288 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -82.0 115.66 21.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -89.49 126.13 35.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.158 0.504 . . . . 0.0 111.02 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.31 154.15 17.33 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -116.5 -60.67 1.83 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.783 0.325 . . . . 0.0 111.118 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -96.43 177.07 5.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.09 -34.95 68.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.79 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -96.53 11.98 33.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.836 0.35 . . . . 0.0 111.545 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -106.79 142.7 36.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.718 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 44' ' ' TYR . 67.0 tp -109.81 127.15 54.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.534 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.8 p -79.58 139.77 37.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.923 0.392 . . . . 0.0 110.392 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.434 HD22 HG11 ' A' ' 29' ' ' VAL . 82.6 mt -119.18 146.28 45.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 41.8 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.358 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -54.18 122.13 9.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.05 30.67 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.819 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -103.69 173.58 6.24 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.431 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 6' ' ' PRO . 17.0 ttpt -124.55 135.66 53.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.521 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG11 HD22 ' A' ' 23' ' ' LEU . 3.3 m -110.93 161.24 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.0 mm -108.41 105.41 18.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.594 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.7 130.06 36.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.427 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.9 mtm -118.06 -25.87 6.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.629 0.252 . . . . 0.0 111.677 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -138.69 123.8 19.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.916 0.388 . . . . 0.0 110.028 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -116.15 127.77 55.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.978 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.47 165.32 13.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -62.76 -28.59 70.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 0.0 111.404 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -160.98 142.37 11.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.63 -88.08 0.98 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.837 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -105.74 132.92 51.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.336 0.588 . . . . 0.0 112.546 -168.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -116.03 140.85 48.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.11 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -97.54 109.85 22.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.188 0.518 . . . . 0.0 109.859 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.07 162.63 25.31 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.76 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 48' ' ' VAL . 4.6 t -113.81 140.86 47.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.894 0.378 . . . . 0.0 110.444 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.521 ' HB3' HD11 ' A' ' 21' ' ' LEU . 49.9 t80 -130.0 116.26 18.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.598 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 t30 67.62 1.69 2.69 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.939 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.04 -45.34 0.97 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.023 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -88.81 145.44 25.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.832 0.349 . . . . 0.0 110.337 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -105.09 164.83 3.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.526 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.68 -163.94 36.61 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.089 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -105.46 134.7 48.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.992 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.417 ' HE2' HG21 ' A' ' 56' ' ' VAL . 43.9 p90 -138.21 148.82 61.25 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.85 135.53 23.65 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.848 2.365 . . . . 0.0 112.016 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.6 p -65.61 -14.13 60.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.478 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 54' ' ' ASN . 0.9 OUTLIER -81.13 4.26 20.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.848 -173.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -126.36 12.8 7.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG21 ' HE2' ' A' ' 51' ' ' PHE . 17.0 m -129.9 138.71 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.12 0 CA-C-O 121.459 0.647 . . . . 0.0 112.07 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -99.24 116.53 31.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.461 173.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.02 -72.71 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -162.73 100.06 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.498 163.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.71 -107.98 0.2 Allowed Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.092 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.934 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -86.45 97.2 10.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.018 0.437 . . . . 0.0 111.789 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.6 mt -137.62 18.25 2.89 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.098 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -179.58 40.05 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.772 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.441 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 17.5 ttt -82.22 129.44 63.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.504 -172.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' HB3' ' HD3' ' A' ' 28' ' ' LYS . 13.3 Cg_exo -70.24 131.24 20.16 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.362 2.041 . . . . 0.0 111.438 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -126.79 128.66 46.94 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.304 0.574 . . . . 0.0 111.008 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -88.27 125.52 34.7 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.624 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -61.58 126.96 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.025 0.44 . . . . 0.0 111.776 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 15.3 mmtm -62.84 -51.61 66.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.738 178.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' HE2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -160.62 154.6 22.83 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.858 -168.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -63.49 116.33 5.48 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.16 0.505 . . . . 0.0 111.901 -173.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -120.31 120.11 35.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.669 176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -87.8 137.45 32.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.944 0.402 . . . . 0.0 110.315 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 22' ' ' SER . . . -122.67 149.0 44.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.041 177.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -126.46 -35.88 2.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.702 0.287 . . . . 0.0 111.144 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.2 mtp85 -84.41 162.84 19.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.392 0.615 . . . . 0.0 111.887 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -72.48 -21.81 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.025 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.24 4.15 51.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.484 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 45.8 mt-10 -105.39 170.54 7.82 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.234 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 27.8 tp -139.76 115.93 10.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.392 173.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 8.0 t -81.14 127.71 32.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.995 0.426 . . . . 0.0 110.013 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 HD22 HG11 ' A' ' 29' ' ' VAL . 44.9 mt -109.47 137.54 47.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.522 -174.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -116.84 120.08 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -56.77 120.75 8.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.99 -20.0 13.29 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.168 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.1 p -105.66 174.61 5.81 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 120.952 0.406 . . . . 0.0 111.166 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.561 ' HD3' ' HB3' ' A' ' 6' ' ' PRO . 6.8 ttmt -129.16 134.43 48.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.933 -175.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD22 ' A' ' 23' ' ' LEU . 2.4 m -108.09 159.4 7.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.156 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 35.0 mm -101.47 108.02 22.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 10.5 t -89.6 102.81 13.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.882 0.373 . . . . 0.0 110.375 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 27.1 mtm -92.82 -39.19 11.34 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.175 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 26.5 tt0 -131.7 123.48 27.84 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.356 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.791 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 56.7 mtpt -118.36 133.97 55.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.776 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -104.1 164.77 11.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -65.26 -38.71 91.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.616 0.246 . . . . 0.0 111.605 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -142.98 149.2 38.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.926 0.394 . . . . 0.0 111.125 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 -118.74 6.28 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.601 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . 77.5 m95 -102.09 135.27 43.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.824 0.345 . . . . 0.0 111.108 -173.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.791 ' CZ2' ' HE3' ' A' ' 34' ' ' LYS . 30.0 m0 -102.0 145.04 29.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.095 175.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 50.6 ttt180 -96.81 106.23 18.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.802 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' HA3' ' HE1' ' A' ' 51' ' ' PHE . . . -139.54 175.93 21.42 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.069 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.533 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 55.6 p -126.92 141.81 51.71 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' HB3' HD11 ' A' ' 21' ' ' LEU . 43.3 t80 -151.19 130.43 12.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.646 0.26 . . . . 0.0 110.911 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 t30 62.0 -97.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.924 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.69 18.3 3.63 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -124.31 149.6 46.38 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.103 -0.548 . . . . 0.0 109.579 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 43' ' ' SER . 1.5 p -136.31 154.96 33.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 152.39 -138.02 6.21 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.829 176.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' TRP . 73.0 m95 -111.82 137.22 50.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.895 0.379 . . . . 0.0 111.452 -173.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 51.8 p90 -135.74 148.94 67.44 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.481 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 55' ' ' TYR . 12.8 Cg_exo -68.81 133.08 26.41 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.479 2.12 . . . . 0.0 112.154 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 p -58.49 -36.98 74.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.528 -0.76 . . . . 0.0 113.03 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 28.6 t-20 -67.93 -21.78 65.09 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.946 0.403 . . . . 0.0 111.594 -174.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 52' ' ' PRO . 10.5 m-85 -90.76 11.38 22.55 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.731 -171.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG21 ' HE2' ' A' ' 51' ' ' PHE . 29.2 m -133.85 170.41 19.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.411 0.624 . . . . 0.0 112.244 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.6 m -147.25 102.31 3.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.595 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.8 mp0 -58.22 -73.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -149.98 19.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.348 1.07 . . . . 0.0 108.583 166.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.04 106.24 0.58 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 113.932 -1.485 . . . . 0.0 110.355 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.731 -0.652 . . . . 0.0 111.657 -170.524 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.879 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 p -64.77 107.66 1.51 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.421 . . . . 0.0 111.574 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.0 174.98 9.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.793 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 58.43 49.03 11.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.387 0.613 . . . . 0.0 109.759 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 20.3 ttt -85.7 124.05 71.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.844 -173.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 28' ' ' LYS . 39.2 Cg_endo -67.73 131.31 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.411 2.074 . . . . 0.0 111.98 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . . . -136.19 128.12 29.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.383 . . . . 0.0 111.298 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -74.43 144.68 44.17 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.89 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 23' ' ' LEU . 95.1 t -85.37 130.42 36.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.883 0.373 . . . . 0.0 110.567 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -98.7 -17.29 18.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.066 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -147.98 143.61 27.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.582 0.229 . . . . 0.0 111.405 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.429 HD22 ' H ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -70.18 117.39 11.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.64 0.733 . . . . 0.0 110.354 174.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 22' ' ' SER . 86.8 t80 -136.71 102.69 4.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.125 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 69.0 mtm -84.84 129.18 34.85 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.028 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 130.21 37.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.264 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -114.45 -3.86 12.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.868 0.366 . . . . 0.0 110.596 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -129.05 174.25 9.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.495 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -73.13 -34.17 65.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.775 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -95.52 22.29 7.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.965 0.412 . . . . 0.0 111.482 -173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -117.03 164.82 14.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.804 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 44' ' ' TYR . 1.0 OUTLIER -128.7 127.77 42.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 48.8 m -73.13 113.13 9.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.839 0.352 . . . . 0.0 110.959 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 51' ' ' PHE . 51.2 mt -101.54 134.92 43.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.3 mm -114.81 116.47 52.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.964 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -53.71 121.29 7.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.62 -23.66 10.9 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.394 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -98.95 -178.57 3.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.252 0.549 . . . . 0.0 111.629 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 6' ' ' PRO . 33.0 ttpt -136.41 136.75 39.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.263 -177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 44' ' ' TYR . 4.2 m -112.07 167.55 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.772 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 30.4 mm -108.27 106.95 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 14.0 t -84.56 102.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.341 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 31.8 mtm -79.59 -38.91 32.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.013 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -136.17 139.69 43.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 -176.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HE2' ' CZ3' ' A' ' 40' ' ' TRP . 87.1 mttt -124.53 112.32 16.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.7 m -72.88 157.4 37.52 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 t -51.1 -41.54 60.07 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 123.328 0.393 . . . . 0.0 111.26 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -162.09 158.64 25.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.04 -107.13 2.81 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.604 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -110.14 149.14 30.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.767 0.318 . . . . 0.0 110.935 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HE2' ' A' ' 34' ' ' LYS . 29.3 m0 -114.02 153.84 28.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.644 177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 33' ' ' GLU . 8.4 ttm180 -96.02 112.71 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.81 172.6 22.2 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.962 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 30' ' ' ILE . 29.3 p -129.35 138.81 51.76 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 122.697 0.399 . . . . 0.0 110.166 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.592 ' HB3' HD21 ' A' ' 21' ' ' LEU . 51.1 t80 -151.93 115.97 4.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.666 0.27 . . . . 0.0 111.595 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 59.32 -90.81 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.573 0.749 . . . . 0.0 112.196 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.38 -13.92 7.92 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.823 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -107.37 151.02 26.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.396 0.617 . . . . 0.0 111.242 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 43' ' ' SER . 2.5 p -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 146.15 -128.14 2.98 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.438 -1.363 . . . . 0.0 113.066 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 63.9 m95 -116.58 139.92 49.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 0.0 111.588 -170.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE1' HG11 ' A' ' 56' ' ' VAL . 50.8 p90 -139.62 153.44 70.32 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.911 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 55' ' ' TYR . 14.9 Cg_exo -69.31 129.53 18.24 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.806 2.338 . . . . 0.0 112.339 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -66.14 -23.2 66.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.14 -22.76 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 111.47 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.476 ' HD2' ' HB2' ' A' ' 52' ' ' PRO . 59.9 m-85 -103.82 24.35 11.39 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 ' CE1' ' A' ' 51' ' ' PHE . 18.3 m -132.83 166.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.346 0.593 . . . . 0.0 111.833 176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.9 m -152.36 105.25 3.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.138 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.9 mp0 -66.24 -77.55 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.285 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -132.94 85.51 2.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.35 -125.19 2.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.156 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.793 -0.622 . . . . 0.0 110.151 -177.435 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.7 p -86.46 119.25 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.865 0.364 . . . . 0.0 111.281 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.1 mp -85.24 62.31 7.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.273 0.559 . . . . 0.0 109.828 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -167.65 56.79 0.07 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.766 -173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.476 ' HG3' ' HG2' ' A' ' 58' ' ' GLU . 14.4 tpt -85.6 118.51 70.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.169 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 4.1 Cg_exo -77.19 127.84 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.543 2.162 . . . . 0.0 111.45 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -135.23 138.75 43.88 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.932 0.396 . . . . 0.0 111.557 -176.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.642 ' HE1' ' HE2' ' A' ' 28' ' ' LYS . 15.3 m-85 -81.85 138.3 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.97 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.94 129.21 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.825 0.345 . . . . 0.0 110.551 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -86.15 -47.86 9.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.954 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.446 ' HB2' ' HD1' ' A' ' 55' ' ' TYR . 90.9 m-85 -128.39 146.94 50.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.507 -175.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -70.29 113.93 7.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.187 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -117.52 100.23 7.51 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt -79.7 108.9 13.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.279 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.54 151.9 30.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.504 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -124.09 -22.59 4.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.092 0.472 . . . . 0.0 110.728 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 17' ' ' ARG . 13.3 ttt180 -116.26 153.86 31.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.278 -173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -66.24 -24.02 66.52 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -87.83 12.42 13.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -112.17 169.73 8.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.548 173.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' PHE . 47.2 tp -130.7 122.96 28.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 174.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -74.43 109.32 7.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.037 0.446 . . . . 0.0 110.631 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.593 HD22 HG11 ' A' ' 29' ' ' VAL . 43.7 mt -99.13 129.44 45.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.277 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.0 mm -109.66 117.44 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -52.7 121.19 6.71 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -15.0 26.62 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.753 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.8 p -107.37 179.87 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.955 0.377 . . . . 0.0 111.215 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.642 ' HE2' ' HE1' ' A' ' 8' ' ' TYR . 23.7 ttmt -132.98 133.34 43.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.482 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.593 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 m -112.76 163.1 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.429 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.66 104.25 16.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.755 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HZ ' ' A' ' 51' ' ' PHE . 3.3 t -85.91 102.77 11.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 24.6 mtm -90.01 -48.77 6.99 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.122 0.486 . . . . 0.0 110.417 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.89 123.04 48.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.701 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -113.73 106.74 14.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.3 t -84.21 138.11 33.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.7 m -65.53 -19.35 65.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.604 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.04 -34.11 76.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.094 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 135.07 -27.81 3.12 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.041 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 116.22 23.2 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.021 0.439 . . . . 0.0 110.446 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.3 m0 -98.86 144.95 27.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.437 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 49' ' ' GLY . 26.1 ttt180 -102.14 105.98 16.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.808 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.39 163.81 23.56 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.474 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.665 ' HB2' HG23 ' A' ' 48' ' ' VAL . 2.7 t -118.14 139.11 51.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.418 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -150.47 127.1 10.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.829 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 60.98 25.31 15.34 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.356 0.598 . . . . 0.0 111.337 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -27.36 20.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -77.24 152.75 34.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.665 HG23 ' HB2' ' A' ' 43' ' ' SER . 3.0 p -138.43 153.33 26.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 159.08 -153.39 24.49 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.769 174.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -101.46 136.21 41.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.991 0.424 . . . . 0.0 111.396 -172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 p90 -139.26 149.77 61.97 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.621 174.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 51' ' ' PHE . 12.4 Cg_exo -71.24 129.57 16.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.473 2.115 . . . . 0.0 111.429 175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 p -60.44 -19.21 55.59 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -71.44 -9.79 58.73 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 11' ' ' PHE . 97.1 m-85 -101.68 0.87 36.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -123.28 157.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.647 0.737 . . . . 0.0 112.598 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -152.65 109.27 3.44 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.517 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 7' ' ' ALA . 7.2 mp0 -65.91 -69.46 0.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.88 0.371 . . . . 0.0 110.211 177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -173.86 27.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.846 0.831 . . . . 0.0 108.767 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.62 166.53 34.47 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.173 -0.921 . . . . 0.0 114.225 -170.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.619 -0.79 . . . . 0.0 108.91 177.329 . . . . . . . . 0 0 . 1 stop_ save_